Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_Cancer_Germline_Mut	i_CGC_Cancer_Molecular_Genetics	i_CGC_Cancer_Somatic_Mut	i_CGC_Cancer_Syndrome	i_CGC_Chr	i_CGC_Chr_Band	i_CGC_GeneID	i_CGC_Name	i_CGC_Other_Germline_Mut	i_CGC_Tissue_Type	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_Ensembl_Gene_ID	i_HGNC_HGNC_ID	i_HGNC_RefSeq_IDs	i_HGNC_Status	i_HGNC_UCSC_ID_supplied_by_UCSC_	i_HGVS_coding_DNA_change	i_HGVS_genomic_change	i_HGVS_protein_change	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERPplusplus_NR	i_dbNSFP_GERPplusplus_RS	i_dbNSFP_GERPplusplus_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_fold_degenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos_1_coor_	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	i_picard_oxoQ	i_t_ALT_F1R2	i_t_ALT_F2R1	i_t_REF_F1R2	i_t_REF_F2R1	i_t_Foxog	pox	qox	pox_cutoff	isArtifactMode	oxoGCut	i_ffpe_Q	i_ffpe_F	i_ffpe_mode	i_ffpe_p_value	i_ffpe_q_value	i_ffpe_p_value_cutoff	i_ffpe_cut	pon_total_counts_coverage_less_8	pon_total_counts_coverage_greater_8	pon_alt_count_greater1_af_greater_01percent	pon_alt_count_greater2_af_greater_03percent	pon_alt_count_greater3_af_greater_1percent	pon_alt_count_greater3_af_greater_3percent	pon_alt_count_greater3_af_greater_20percent	pon_alt_count_greater10_af_greater_20percent	tumor_only_pon_weight	tumor_only_pass_weight	tumor_only_pass	pon_loglike	pon_weight	pon_pass_grid	pon_pass_loglike	pon_pass_weight	pon_coding	pon_low_alt_count	read_depth	Cosmic(v75) Counts
EP300	2033	broad.mit.edu	37	22	41564549	41564549	+	Missense_Mutation	SNP	G	G	A			AC-V01-Tumor-SM-9J45S	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V01-Tumor-SM-9J45S	none	g.chr22:41564549G>A	ENST00000263253.7	+	24	5190	c.3971G>A	c.(3970-3972)aGa>aAa	p.R1324K		NM_001429.3	NP_001420.2	Q09472	EP300_HUMAN	E1A binding protein p300	1324.0					apoptosis|cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|histone H4 acetylation|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|response to estrogen stimulus|response to hypoxia	centrosome|histone acetyltransferase complex	androgen receptor binding|beta-catenin binding|DNA binding|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|transcription coactivator activity|zinc ion binding			NS(2)|breast(11)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(31)|kidney(5)|large_intestine(31)|liver(2)|lung(33)|ovary(2)|pancreas(4)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(16)	171.0						GTCACTGTTAGAGTAGTTCAT	0.453			"""T,  N, F, Mis, O"""	"""MLL, RUNXBP2"""	"""colorectal, breast, pancreatic, AML, ALL, DLBCL"""				Rubinstein-Taybi syndrome																												Rec	yes		22.0	22q13	2033.0	300 kd E1A-Binding protein gene		"""L, E"""	0													144.0	135.0	138.0					22																	41564549.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Broad Thumb-Hallux syndrome	ENSG00000100393	HGNC:3373	NM_001429	Approved	uc003azl.4	ENST00000263253.7:c.3971G>A	22.37:g.41564549G>A	ENSP00000263253:p.Arg1324Lys		B1AKC2	ENST00000263253.7	37	CCDS14010.1	.	.	.	.	.	.	.	.	.	.	G	32	5.10809	0.94292	.	.	ENSG00000100393	ENST00000263253	D	0.94417	-3.42	5.76	5.76	0.90799	.	0	0.44097	D	0.000482	D	0.98128	0.9382	M	0.93197	3.39	0.47441	D	0.999426	D	0.69078	0.997	D	0.79108	0.992	D	0.98683	1.0693	10	0.87932	D	0	-13.4022	19.9731	0.97292	0.0:0.0:1.0:0.0	.	1324	Q09472	EP300_HUMAN	K	1324	ENSP00000263253:R1324K	ENSP00000263253:R1324K	R	+	2	0	EP300	39894495	1	0.71417	0.552	0.28243	0.986	0.74619	9.869	0.9981	2.715	0.92844	0.563	0.77884	AGA	EP300-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000320600.1	481.415435	KEEP		+	481.949571	0.459239	169	199					44.61	81	110	92	135	0.424084	0.0	0.0	1	0	0	33.04	0.575916	1	1.39e-60	2.64e-60	1.0	0	47	7942	265	71	2	7	0	0	0.000164	0.003	1	-20.0	1.0	1	1	1	1	0	368	0.0
KMT2D	8085	broad.mit.edu	37	12	49427111	49427111	+	Nonsense_Mutation	SNP	G	G	A			AC-V04-Tumor-SM-9J45V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V04-Tumor-SM-9J45V	none	g.chr12:49427111G>A	ENST00000301067.7	-	39	11376	c.11377C>T	c.(11377-11379)Caa>Taa	p.Q3793*		NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D																		TGGGGTGGTTGAGGGGACAGC	0.672																																														0													14.0	17.0	16.0					12																	49427111.0		1972.0	4142.0	6114.0	SO:0001587	stop_gained			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.11377C>T	12.37:g.49427111G>A	ENSP00000301067:p.Gln3793*			ENST00000301067.7	37	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	G	51	17.626721	0.99890	.	.	ENSG00000167548	ENST00000301067	.	.	.	5.02	5.02	0.67125	.	0.000000	0.33327	N	0.005036	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	17.4938	0.87712	0.0:0.0:1.0:0.0	.	.	.	.	X	3793	.	ENSP00000301067:Q3793X	Q	-	1	0	MLL2	47713378	0.982000	0.34865	0.304000	0.25085	0.721000	0.41392	3.510000	0.53393	2.505000	0.84491	0.462000	0.41574	CAA	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	34.504623	KEEP		-	34.963023	0.384615	15	24					37.42	13	3	8	23	0.8125	0.0	0.0	1	0	0	29.88	0.1875	1	3.35478e-16	4.77221e-16	0.132662	0	1296	6875	150	12	0	0	0	0	4.3255e-05	0.003	1	-20.0	1.0	1	1	1	1	0	39	0.0
KMT2D	8085	broad.mit.edu	37	12	49446999	49446999	+	Nonsense_Mutation	SNP	C	C	T			AC-V05-Tumor-SM-9J45W	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V05-Tumor-SM-9J45W	none	g.chr12:49446999C>T	ENST00000301067.7	-	7	944	c.945G>A	c.(943-945)tgG>tgA	p.W315*		NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D																		CCTTGCACTTCCAAGAGTGAG	0.458																																														0													184.0	184.0	184.0					12																	49446999.0		2048.0	4177.0	6225.0	SO:0001587	stop_gained			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.945G>A	12.37:g.49446999C>T	ENSP00000301067:p.Trp315*			ENST00000301067.7	37	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	C	37	6.188132	0.97362	.	.	ENSG00000167548	ENST00000301067	.	.	.	5.78	5.78	0.91487	.	0.000000	0.33834	N	0.004509	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	18.7696	0.91885	0.0:1.0:0.0:0.0	.	.	.	.	X	315	.	ENSP00000301067:W315X	W	-	3	0	MLL2	47733266	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	7.728000	0.84847	2.733000	0.93635	0.561000	0.74099	TGG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	1.473386	KEEP		-	12.172662	0.102941	7	61					44.99	3	5	30	38	0.625	0.0	0.0	1	0	0	30.2	0.375	1	5.18039e-06	5.66017e-06	0.038147	0	91	8054	101	71	15	2	0	0	0.0001595574	0.003	1	-3.626658	0.9996046	1	1	1	1	0	68	0.0
PIK3CB	5291	broad.mit.edu	37	3	138433351	138433351	+	Missense_Mutation	SNP	T	T	G			AC-V05-Tumor-SM-9J45W	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V05-Tumor-SM-9J45W	none	g.chr3:138433351T>G	ENST00000477593.1	-	8	1334	c.1261A>C	c.(1261-1263)Aat>Cat	p.N421H	PIK3CB_ENST00000289153.2_Missense_Mutation_p.N421H			P42338	PK3CB_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	421.0	C2 PI3K-type.				activation of MAPK activity|chemotaxis|fibroblast growth factor receptor signaling pathway|G-protein coupled receptor protein signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell receptor signaling pathway	phosphatidylinositol 3-kinase complex	1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity			NS(1)|breast(3)|endometrium(5)|kidney(2)|large_intestine(4)|lung(17)|ovary(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(4)	41.0						TTAGAGGGATTAATAGTTTTC	0.308																																														0													140.0	133.0	135.0					3																	138433351.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000051382	HGNC:8976		Approved	uc011bmq.3	ENST00000477593.1:c.1261A>C	3.37:g.138433351T>G	ENSP00000418143:p.Asn421His		D3DNF0|Q24JU2	ENST00000477593.1	37	CCDS3104.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	T|T	14.21|14.21	2.466249|2.466249	0.43839|0.43839	.|.	.|.	ENSG00000051382|ENSG00000051382	ENST00000493568|ENST00000477593;ENST00000289153	.|T;T	.|0.70516	.|-0.49;-0.49	5.46|5.46	5.46|5.46	0.80206|0.80206	.|C2 calcium/lipid-binding domain, CaLB (1);Phosphoinositide 3-kinase, C2 (2);	.|0.554996	.|0.19124	.|N	.|0.122100	T|T	0.47002|0.47002	0.1422|0.1422	N|N	0.02011|0.02011	-0.69|-0.69	0.80722|0.80722	D|D	1|1	.|B;B	.|0.12630	.|0.004;0.006	.|B;B	.|0.13407	.|0.009;0.007	T|T	0.46693|0.46693	-0.9173|-0.9173	5|10	.|0.45353	.|T	.|0.12	-15.5739|-15.5739	14.3971|14.3971	0.67018|0.67018	0.0:0.0:0.0:1.0|0.0:0.0:0.0:1.0	.|.	.|421;25	.|P42338;B4DZI3	.|PK3CB_HUMAN;.	F|H	69|421	.|ENSP00000418143:N421H;ENSP00000289153:N421H	.|ENSP00000289153:N421H	L|N	-|-	3|1	2|0	PIK3CB|PIK3CB	139916041|139916041	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.997000|0.997000	0.91878|0.91878	3.738000|3.738000	0.55067|0.55067	2.189000|2.189000	0.69895|0.69895	0.528000|0.528000	0.53228|0.53228	TTA|AAT	PIK3CB-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000358019.1	-6.110227	KEEP		-	7.42308	0.096386	8	75					44.99	1	7	43	42	0.125	0.0	0.0	1	0	0	30.2		0	0.0	0.0	0.038147	0	48	8185	85	12	4	0	0	0	4.908868e-05	0.003	1	-6.339787	1.0	1	1	1	1	0	83	0.0
PIK3CA	5290	broad.mit.edu	37	3	178921549	178921549	+	Missense_Mutation	SNP	T	T	G			AC-V05-Tumor-SM-9J45W	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V05-Tumor-SM-9J45W	none	g.chr3:178921549T>G	ENST00000263967.3	+	5	1188	c.1031T>G	c.(1030-1032)gTg>gGg	p.V344G		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	344.0					epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.V344G(8)|p.V344A(5)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269.0	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			GCAACCTACGTGAATGTAAAT	0.303		57.0	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																									Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3.0	3q26.3	5290.0	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	13	Substitution - Missense(13)	endometrium(6)|large_intestine(4)|cervix(2)|central_nervous_system(1)											68.0	67.0	67.0					3																	178921549.0		1808.0	4073.0	5881.0	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	ENST00000263967.3:c.1031T>G	3.37:g.178921549T>G	ENSP00000263967:p.Val344Gly		Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	T	23.2	4.391827	0.83011	.	.	ENSG00000121879	ENST00000263967	T	0.71103	-0.54	5.41	5.41	0.78517	C2 calcium-dependent membrane targeting (1);C2 calcium/lipid-binding domain, CaLB (1);Phosphoinositide 3-kinase, C2 (1);	0.000000	0.85682	D	0.000000	D	0.83367	0.5239	M	0.77103	2.36	0.80722	D	1	D	0.76494	0.999	D	0.68353	0.957	D	0.84581	0.0661	10	0.49607	T	0.09	-22.945	15.721	0.77710	0.0:0.0:0.0:1.0	.	344	P42336	PK3CA_HUMAN	G	344	ENSP00000263967:V344G	ENSP00000263967:V344G	V	+	2	0	PIK3CA	180404243	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	7.606000	0.82863	2.166000	0.68216	0.402000	0.26972	GTG	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000348409.2	7.202042	KEEP		+	14.166852	0.132075	7	46					44.99	4	3	27	20	0.571429	0.0	0.0	1	0	0	30.2		0	0.0	0.0	0.02938	0	57	8098	148	30	0	0	0	0	3.830097e-05	0.003	1	-13.6625	0.9999999	1	1	1	1	0	53	13.0
PIK3CA	5290	broad.mit.edu	37	3	178936082	178936082	+	Missense_Mutation	SNP	G	G	A	rs121913273		AC-V06-Tumor-SM-9J45X	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V06-Tumor-SM-9J45X	none	g.chr3:178936082G>A	ENST00000263967.3	+	10	1781	c.1624G>A	c.(1624-1626)Gaa>Aaa	p.E542K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	542.0	PI3K helical.		E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation).|E -> Q (in cancer).|E -> V (in cancer).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E542K(545)|p.E542Q(10)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269.0	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TCCTCTCTCTGAAATCACTGA	0.333	E542K(BT483_BREAST)|E542K(CAL51_BREAST)|E542K(HGC27_STOMACH)|E542K(IM95_STOMACH)|E542K(JHUEM1_ENDOMETRIUM)|E542K(NCIH1341_LUNG)|E542K(SW948_LARGE_INTESTINE)|E542K(T84_LARGE_INTESTINE)|E542K(VMCUB1_URINARY_TRACT)	57.0	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																									Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3.0	3q26.3	5290.0	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	555	Substitution - Missense(555)	breast(176)|large_intestine(166)|urinary_tract(45)|endometrium(37)|skin(19)|lung(18)|stomach(16)|ovary(16)|thyroid(14)|upper_aerodigestive_tract(9)|central_nervous_system(7)|cervix(6)|liver(6)|oesophagus(5)|penis(4)|kidney(3)|soft_tissue(2)|haematopoietic_and_lymphoid_tissue(2)|prostate(2)|biliary_tract(1)|pituitary(1)											56.0	56.0	56.0					3																	178936082.0		1809.0	4069.0	5878.0	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	ENST00000263967.3:c.1624G>A	3.37:g.178936082G>A	ENSP00000263967:p.Glu542Lys		Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	34	5.360420	0.95877	.	.	ENSG00000121879	ENST00000263967	T	0.62105	0.05	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.69287	0.3094	L	0.41356	1.27	0.80722	D	1	D	0.65815	0.995	D	0.63192	0.912	T	0.60296	-0.7291	10	0.09843	T	0.71	-23.9623	20.0024	0.97423	0.0:0.0:1.0:0.0	.	542	P42336	PK3CA_HUMAN	K	542	ENSP00000263967:E542K	ENSP00000263967:E542K	E	+	1	0	PIK3CA	180418776	1.000000	0.71417	1.000000	0.80357	0.978000	0.69477	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAA	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000348409.2	129.992115	KEEP		+	207.104306	0.147287	95	550					42.25	56	69	337	380	0.448	0.0	0.0	1	0	0	31.39	0.552	1	5.05957e-44	8.28553e-44	0.870114	0	107	7922	236	53	8	7	0	0	0.0001726903	0.003	1	-3.075783	0.9986492	1	1	1	1	0	645	280.0
KMT2D	8085	broad.mit.edu	37	12	49440141	49440141	+	Nonsense_Mutation	SNP	G	G	C			AC-V06-Tumor-SM-9J45X	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V06-Tumor-SM-9J45X	none	g.chr12:49440141G>C	ENST00000301067.7	-	16	4484	c.4485C>G	c.(4483-4485)taC>taG	p.Y1495*		NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D																		CACAGTGTGTGTAACTATTCT	0.547																																														0													96.0	106.0	103.0					12																	49440141.0		2142.0	4244.0	6386.0	SO:0001587	stop_gained			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.4485C>G	12.37:g.49440141G>C	ENSP00000301067:p.Tyr1495*			ENST00000301067.7	37	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	G	42	9.688262	0.99238	.	.	ENSG00000167548	ENST00000301067	.	.	.	5.17	1.25	0.21368	.	0.000000	0.33382	N	0.004977	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	8.7065	0.34358	0.3894:0.0:0.6106:0.0	.	.	.	.	X	1495	.	ENSP00000301067:Y1495X	Y	-	3	2	MLL2	47726408	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	1.082000	0.30803	0.206000	0.20587	0.655000	0.94253	TAC	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	81.983306	KEEP		-	90.782572	0.239437	34	108					42.25	22	19	55	81	0.536585	0.0	0.0	1	0	0	31.39	0.463415	0	0.0	0.0	0.812448	0	94	8000	185	50	4	0	0	0	8.406171e-05	0.003	1	-19.99999	0.9999956	1	1	1	1	0	142	0.0
MTOR	2475	broad.mit.edu	37	1	11194516	11194516	+	Missense_Mutation	SNP	G	G	A			AC-V08-Tumor-SM-9J45Z	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V08-Tumor-SM-9J45Z	none	g.chr1:11194516G>A	ENST00000361445.4	-	37	5214	c.5138C>T	c.(5137-5139)gCc>gTc	p.A1713V	MTOR_ENST00000495435.1_5'UTR	NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	1713.0	FAT.				cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						GTGCTGGAAGGCATCGATCTG	0.542																																														0													170.0	124.0	140.0					1																	11194516.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.5138C>T	1.37:g.11194516G>A	ENSP00000354558:p.Ala1713Val		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37	CCDS127.1	.	.	.	.	.	.	.	.	.	.	G	31	5.079859	0.94050	.	.	ENSG00000198793	ENST00000361445	T	0.79845	-1.31	4.91	4.91	0.64330	PIK-related kinase (1);PIK-related kinase, FAT (1);Armadillo-like helical (1);	0.000000	0.85682	D	0.000000	D	0.92267	0.7547	M	0.92923	3.36	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	D	0.94130	0.7387	10	0.87932	D	0	-18.3973	18.4857	0.90828	0.0:0.0:1.0:0.0	.	1713	P42345	MTOR_HUMAN	V	1713	ENSP00000354558:A1713V	ENSP00000354558:A1713V	A	-	2	0	MTOR	11117103	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	9.131000	0.94446	2.434000	0.82447	0.655000	0.94253	GCC	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	181.72501	KEEP		-	183.226693	0.626168	67	40					44.91	33	48	16	31	0.407407	0.0	0.0	1	0	0	30.56	0.592593	1	5.94106e-25	9.35913e-25	0.139131	0	47	8012	214	51	7	3	0	0	0.0001614861	0.003	1	-20.0	0.999987	1	1	1	1	0	107	0.0
MTOR	2475	broad.mit.edu	37	1	11194516	11194516	+	Missense_Mutation	SNP	G	G	A			AC-V08-Tumor-SM-9J461	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V08-Tumor-SM-9J461	none	g.chr1:11194516G>A	ENST00000361445.4	-	37	5214	c.5138C>T	c.(5137-5139)gCc>gTc	p.A1713V	MTOR_ENST00000495435.1_5'UTR	NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	1713.0	FAT.				cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						GTGCTGGAAGGCATCGATCTG	0.542																																														0													170.0	124.0	140.0					1																	11194516.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.5138C>T	1.37:g.11194516G>A	ENSP00000354558:p.Ala1713Val		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37	CCDS127.1	.	.	.	.	.	.	.	.	.	.	G	31	5.079859	0.94050	.	.	ENSG00000198793	ENST00000361445	T	0.79845	-1.31	4.91	4.91	0.64330	PIK-related kinase (1);PIK-related kinase, FAT (1);Armadillo-like helical (1);	0.000000	0.85682	D	0.000000	D	0.92267	0.7547	M	0.92923	3.36	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	D	0.94130	0.7387	10	0.87932	D	0	-18.3973	18.4857	0.90828	0.0:0.0:1.0:0.0	.	1713	P42345	MTOR_HUMAN	V	1713	ENSP00000354558:A1713V	ENSP00000354558:A1713V	A	-	2	0	MTOR	11117103	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	9.131000	0.94446	2.434000	0.82447	0.655000	0.94253	GCC	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	130.368839	KEEP		-	132.109176	0.658228	52	27					42.94	23	37	21	11	0.383333	0.0	0.0	1	0	0	30.18	0.616667	1	3.88204e-17	5.8914e-17	0.139131	0	47	8012	214	51	7	3	0	0	0.000164011	0.003	1	-19.99406	0.9999881	1	1	1	1	0	79	0.0
MTOR	2475	broad.mit.edu	37	1	11194516	11194516	+	Missense_Mutation	SNP	G	G	A			AC-V08-Tumor-SM-9J462	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V08-Tumor-SM-9J462	none	g.chr1:11194516G>A	ENST00000361445.4	-	37	5214	c.5138C>T	c.(5137-5139)gCc>gTc	p.A1713V	MTOR_ENST00000495435.1_5'UTR	NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	1713.0	FAT.				cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						GTGCTGGAAGGCATCGATCTG	0.542																																														0													170.0	124.0	140.0					1																	11194516.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.5138C>T	1.37:g.11194516G>A	ENSP00000354558:p.Ala1713Val		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37	CCDS127.1	.	.	.	.	.	.	.	.	.	.	G	31	5.079859	0.94050	.	.	ENSG00000198793	ENST00000361445	T	0.79845	-1.31	4.91	4.91	0.64330	PIK-related kinase (1);PIK-related kinase, FAT (1);Armadillo-like helical (1);	0.000000	0.85682	D	0.000000	D	0.92267	0.7547	M	0.92923	3.36	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	D	0.94130	0.7387	10	0.87932	D	0	-18.3973	18.4857	0.90828	0.0:0.0:1.0:0.0	.	1713	P42345	MTOR_HUMAN	V	1713	ENSP00000354558:A1713V	ENSP00000354558:A1713V	A	-	2	0	MTOR	11117103	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	9.131000	0.94446	2.434000	0.82447	0.655000	0.94253	GCC	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	104.469322	KEEP		-	105.620065	0.637681	44	25					39.64	17	34	15	13	0.333333	0.0	0.0	1	0	0	31.15	0.666667	1	6.87076e-12	1.0013e-11	0.323286	0	47	8012	214	51	7	3	0	0	0.0001624051	0.003	1	-18.43535	0.9999874	1	1	1	1	0	69	0.0
MTOR	2475	broad.mit.edu	37	1	11187790	11187790	+	Missense_Mutation	SNP	C	C	T			AC-V09-Tumor-SM-9J463	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V09-Tumor-SM-9J463	none	g.chr1:11187790C>T	ENST00000361445.4	-	44	6183	c.6107G>A	c.(6106-6108)cGt>cAt	p.R2036H	MTOR_ENST00000376838.1_Missense_Mutation_p.R241H	NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	2036.0					cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						AAAGTACAAACGAGATGCCTC	0.542																																														0													224.0	231.0	228.0					1																	11187790.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.6107G>A	1.37:g.11187790C>T	ENSP00000354558:p.Arg2036His		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37	CCDS127.1	.	.	.	.	.	.	.	.	.	.	C	36	5.730520	0.96856	.	.	ENSG00000198793	ENST00000361445;ENST00000376838	T;T	0.11930	2.92;2.73	5.8	5.8	0.92144	FKBP12-rapamycin-associated protein, FKBP12-rapamycin-binding (3);	0.000000	0.85682	D	0.000000	T	0.51719	0.1691	M	0.93678	3.445	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	T	0.63373	-0.6652	10	0.87932	D	0	-9.885	20.063	0.97692	0.0:1.0:0.0:0.0	.	2036	P42345	MTOR_HUMAN	H	2036;241	ENSP00000354558:R2036H;ENSP00000366034:R241H	ENSP00000354558:R2036H	R	-	2	0	MTOR	11110377	1.000000	0.71417	0.996000	0.52242	0.968000	0.65278	7.456000	0.80751	2.735000	0.93741	0.655000	0.94253	CGT	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	31.119502	KEEP		-	40.982764	0.173469	17	81					45.88	7	13	40	57	0.65	0.0	0.0	1	0	0	33.84	0.35	1	3.99206e-14	4.95068e-14	1.0	0	47	8242	28	4	13	0	0	0	0.0001011779	0.003	1	-11.82896	1.0	1	1	1	1	0	98	0.0
MTOR	2475	broad.mit.edu	37	1	11187790	11187790	+	Missense_Mutation	SNP	C	C	T			AC-V09-Tumor-SM-9J464	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V09-Tumor-SM-9J464	none	g.chr1:11187790C>T	ENST00000361445.4	-	44	6183	c.6107G>A	c.(6106-6108)cGt>cAt	p.R2036H	MTOR_ENST00000376838.1_Missense_Mutation_p.R241H	NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	2036.0					cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						AAAGTACAAACGAGATGCCTC	0.542																																														0													224.0	231.0	228.0					1																	11187790.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.6107G>A	1.37:g.11187790C>T	ENSP00000354558:p.Arg2036His		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37	CCDS127.1	.	.	.	.	.	.	.	.	.	.	C	36	5.730520	0.96856	.	.	ENSG00000198793	ENST00000361445;ENST00000376838	T;T	0.11930	2.92;2.73	5.8	5.8	0.92144	FKBP12-rapamycin-associated protein, FKBP12-rapamycin-binding (3);	0.000000	0.85682	D	0.000000	T	0.51719	0.1691	M	0.93678	3.445	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	T	0.63373	-0.6652	10	0.87932	D	0	-9.885	20.063	0.97692	0.0:1.0:0.0:0.0	.	2036	P42345	MTOR_HUMAN	H	2036;241	ENSP00000354558:R2036H;ENSP00000366034:R241H	ENSP00000354558:R2036H	R	-	2	0	MTOR	11110377	1.000000	0.71417	0.996000	0.52242	0.968000	0.65278	7.456000	0.80751	2.735000	0.93741	0.655000	0.94253	CGT	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	118.381244	KEEP		-	119.177901	0.40404	40	59					44.17	29	15	43	30	0.340909	0.0	0.0	1	0	0	35.19	0.659091	1	8.16904e-11	9.35487e-11	1.0	0	47	8242	28	4	13	0	0	0	0.0001036431	0.003	1	-20.0	1.0	1	1	1	1	0	99	0.0
PIK3CB	5291	broad.mit.edu	37	3	138433351	138433351	+	Missense_Mutation	SNP	T	T	G			AC-V09-Tumor-SM-9J464	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V09-Tumor-SM-9J464	none	g.chr3:138433351T>G	ENST00000477593.1	-	8	1334	c.1261A>C	c.(1261-1263)Aat>Cat	p.N421H	PIK3CB_ENST00000289153.2_Missense_Mutation_p.N421H			P42338	PK3CB_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	421.0	C2 PI3K-type.				activation of MAPK activity|chemotaxis|fibroblast growth factor receptor signaling pathway|G-protein coupled receptor protein signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell receptor signaling pathway	phosphatidylinositol 3-kinase complex	1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity			NS(1)|breast(3)|endometrium(5)|kidney(2)|large_intestine(4)|lung(17)|ovary(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(4)	41.0						TTAGAGGGATTAATAGTTTTC	0.308																																														0													140.0	133.0	135.0					3																	138433351.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000051382	HGNC:8976		Approved	uc011bmq.3	ENST00000477593.1:c.1261A>C	3.37:g.138433351T>G	ENSP00000418143:p.Asn421His		D3DNF0|Q24JU2	ENST00000477593.1	37	CCDS3104.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	T|T	14.21|14.21	2.466249|2.466249	0.43839|0.43839	.|.	.|.	ENSG00000051382|ENSG00000051382	ENST00000493568|ENST00000477593;ENST00000289153	.|T;T	.|0.70516	.|-0.49;-0.49	5.46|5.46	5.46|5.46	0.80206|0.80206	.|C2 calcium/lipid-binding domain, CaLB (1);Phosphoinositide 3-kinase, C2 (2);	.|0.554996	.|0.19124	.|N	.|0.122100	T|T	0.47002|0.47002	0.1422|0.1422	N|N	0.02011|0.02011	-0.69|-0.69	0.80722|0.80722	D|D	1|1	.|B;B	.|0.12630	.|0.004;0.006	.|B;B	.|0.13407	.|0.009;0.007	T|T	0.46693|0.46693	-0.9173|-0.9173	5|10	.|0.45353	.|T	.|0.12	-15.5739|-15.5739	14.3971|14.3971	0.67018|0.67018	0.0:0.0:0.0:1.0|0.0:0.0:0.0:1.0	.|.	.|421;25	.|P42338;B4DZI3	.|PK3CB_HUMAN;.	F|H	69|421	.|ENSP00000418143:N421H;ENSP00000289153:N421H	.|ENSP00000289153:N421H	L|N	-|-	3|1	2|0	PIK3CB|PIK3CB	139916041|139916041	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.997000|0.997000	0.91878|0.91878	3.738000|3.738000	0.55067|0.55067	2.189000|2.189000	0.69895|0.69895	0.528000|0.528000	0.53228|0.53228	TTA|AAT	PIK3CB-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000358019.1	-14.466315	KEEP		-	9.070842	0.077519	10	119					44.17	1	10	76	52	0.0909091	0.0	0.0	1	0	0	35.19		0	0.0	0.0	1.0	0	48	8185	85	12	4	0	0	0	4.87471e-05	0.003	1	-6.02844	1.0	1	1	1	1	0	129	0.0
EGFR	1956	broad.mit.edu	37	7	55220269	55220269	+	Missense_Mutation	SNP	C	C	T			AC-V10-Tumor-SM-9J465	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V10-Tumor-SM-9J465	none	g.chr7:55220269C>T	ENST00000275493.2	+	6	836	c.659C>T	c.(658-660)tCc>tTc	p.S220F	EGFR_ENST00000454757.2_Missense_Mutation_p.S167F|EGFR_ENST00000342916.3_Missense_Mutation_p.S220F|EGFR_ENST00000344576.2_Missense_Mutation_p.S220F|EGFR_ENST00000420316.2_Missense_Mutation_p.S220F|EGFR_ENST00000455089.1_Missense_Mutation_p.S175F|EGFR_ENST00000442591.1_Missense_Mutation_p.S220F	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	220.0					activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110.0	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	CAGCAGTGCTCCGGGCGCTGC	0.597		8.0	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC			Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)																										yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956.0	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""		"""E, O"""	0													106.0	119.0	115.0					7																	55220269.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	ENST00000275493.2:c.659C>T	7.37:g.55220269C>T	ENSP00000275493:p.Ser220Phe		O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	C	22.3	4.277059	0.80580	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000395504;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000454757;ENST00000533450	T;T;T;T;T;T;T	0.63580	-0.05;-0.05;-0.05;-0.05;-0.05;-0.05;-0.05	5.3	5.3	0.74995	Growth factor, receptor (1);Furin-like cysteine-rich domain (1);	0.000000	0.85682	D	0.000000	T	0.80706	0.4674	M	0.81341	2.54	0.58432	D	0.999996	D;D;D;D;D	0.89917	0.996;0.996;1.0;0.999;0.991	D;D;D;D;D	0.85130	0.969;0.965;0.997;0.99;0.958	T	0.83099	-0.0129	10	0.66056	D	0.02	.	17.5084	0.87753	0.0:1.0:0.0:0.0	.	175;220;220;220;220	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	F	175;220;90;220;220;220;220;167;14	ENSP00000415559:S175F;ENSP00000342376:S220F;ENSP00000345973:S220F;ENSP00000413843:S220F;ENSP00000275493:S220F;ENSP00000410031:S220F;ENSP00000395243:S167F	ENSP00000275493:S220F	S	+	2	0	EGFR	55187763	1.000000	0.71417	0.921000	0.36526	0.919000	0.55068	4.525000	0.60559	2.448000	0.82819	0.655000	0.94253	TCC	EGFR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000251456.2	-2.954949	KEEP		+	26.156105	0.084337	14	152					48.94	7	11	78	113	0.611111	0.0	0.0	1	0	0	29.03	0.388889	1	1.02788e-11	1.48844e-11	0.00499	0	91	8049	84	44	62	4	0	0	0.0005030985	0.003	1	-3.317725	0.9712355	1	1	1	1	0	166	0.0
PIK3R1	5295	broad.mit.edu	37	5	67591102	67591102	+	Missense_Mutation	SNP	C	C	G			AC-V10-Tumor-SM-9J465	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V10-Tumor-SM-9J465	none	g.chr5:67591102C>G	ENST00000521381.1	+	13	2311	c.1695C>G	c.(1693-1695)agC>agG	p.S565R	PIK3R1_ENST00000523872.1_Missense_Mutation_p.S202R|PIK3R1_ENST00000320694.8_Missense_Mutation_p.S265R|PIK3R1_ENST00000521657.1_Missense_Mutation_p.S565R|PIK3R1_ENST00000274335.5_Missense_Mutation_p.S565R|PIK3R1_ENST00000396611.1_Missense_Mutation_p.S565R|PIK3R1_ENST00000336483.5_Missense_Mutation_p.S295R	NM_181523.2	NP_852664.1	P27986	P85A_HUMAN	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	565.0					epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|growth hormone receptor signaling pathway|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|interspecies interaction between organisms|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of establishment of protein localization in plasma membrane|positive regulation of glucose import|T cell costimulation|T cell receptor signaling pathway	1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex	1-phosphatidylinositol binding|ErbB-3 class receptor binding|insulin binding|insulin receptor binding|insulin receptor substrate binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase regulator activity|protein phosphatase binding	p.0?(1)|p.?(1)		breast(12)|central_nervous_system(31)|cervix(1)|endometrium(68)|haematopoietic_and_lymphoid_tissue(5)|kidney(1)|large_intestine(32)|lung(10)|ovary(9)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(2)	178.0		Lung NSC(167;1.99e-05)|Prostate(74;0.00308)|Ovarian(174;0.00473)|Colorectal(97;0.0176)		OV - Ovarian serous cystadenocarcinoma(47;3.76e-51)|Lung(70;0.0211)	Isoproterenol(DB01064)	GTATGAACAGCATTAAACCAG	0.373			"""Mis, F, O"""		"""gliobastoma, ovarian, colorectal"""					TCGA GBM(4;<1E-08)																											Rec	yes		5	5q13.1	5295.0	"""phosphoinositide-3-kinase, regulatory subunit 1 (alpha)"""		"""E, O"""	2	Whole gene deletion(1)|Unknown(1)	large_intestine(1)|lung(1)											151.0	149.0	150.0					5																	67591102.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000145675	HGNC:8979	NM_181504	Approved	uc003jva.3	ENST00000521381.1:c.1695C>G	5.37:g.67591102C>G	ENSP00000428056:p.Ser565Arg		D3DWA0|Q15747|Q4VBZ7|Q53EM6|Q8IXA2|Q8N1C5	ENST00000521381.1	37	CCDS3993.1	.	.	.	.	.	.	.	.	.	.	C	20.5	4.008807	0.75046	.	.	ENSG00000145675	ENST00000521381;ENST00000521657;ENST00000396611;ENST00000274335;ENST00000320694;ENST00000336483;ENST00000523872	T;T;T;T;T;T;T	0.38560	1.13;1.13;1.13;1.13;1.13;1.13;1.13	4.7	2.89	0.33648	.	0.000000	0.85682	D	0.000000	T	0.61035	0.2315	M	0.76574	2.34	0.80722	D	1	D;P;P;D	0.89917	1.0;0.865;0.865;1.0	D;P;P;D	0.76071	0.967;0.642;0.642;0.987	T	0.62548	-0.6831	10	0.59425	D	0.04	-18.2259	11.2468	0.49002	0.0:0.8497:0.0:0.1503	.	235;295;265;565	B7Z2N8;P27986-2;P27986-3;P27986	.;.;.;P85A_HUMAN	R	565;565;565;565;265;295;202	ENSP00000428056:S565R;ENSP00000429277:S565R;ENSP00000379855:S565R;ENSP00000274335:S565R;ENSP00000323512:S265R;ENSP00000338554:S295R;ENSP00000430098:S202R	ENSP00000274335:S565R	S	+	3	2	PIK3R1	67626858	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	3.911000	0.56378	0.684000	0.31448	0.585000	0.79938	AGC	PIK3R1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000254013.2	-12.047008	KEEP		+	22.680936	0.071038	13	170					48.94	6	11	84	119	0.647059	0.0	0.0	1	0	0	29.03	0.352941	0	0.0	0.0	0.004007	0	47	8058	143	75	10	0	0	0	0.0001173525	0.003	1	-5.763127	0.9996679	1	1	1	1	0	183	1.0
PIK3CA	5290	broad.mit.edu	37	3	178936082	178936082	+	Missense_Mutation	SNP	G	G	A	rs121913273		AC-V10-Tumor-SM-9J466	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V10-Tumor-SM-9J466	none	g.chr3:178936082G>A	ENST00000263967.3	+	10	1781	c.1624G>A	c.(1624-1626)Gaa>Aaa	p.E542K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	542.0	PI3K helical.		E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation).|E -> Q (in cancer).|E -> V (in cancer).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E542K(545)|p.E542Q(10)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269.0	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TCCTCTCTCTGAAATCACTGA	0.333	E542K(BT483_BREAST)|E542K(CAL51_BREAST)|E542K(HGC27_STOMACH)|E542K(IM95_STOMACH)|E542K(JHUEM1_ENDOMETRIUM)|E542K(NCIH1341_LUNG)|E542K(SW948_LARGE_INTESTINE)|E542K(T84_LARGE_INTESTINE)|E542K(VMCUB1_URINARY_TRACT)	57.0	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																									Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290.0	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	555	Substitution - Missense(555)	breast(176)|large_intestine(166)|urinary_tract(45)|endometrium(37)|skin(19)|lung(18)|stomach(16)|ovary(16)|thyroid(14)|upper_aerodigestive_tract(9)|central_nervous_system(7)|cervix(6)|liver(6)|oesophagus(5)|penis(4)|kidney(3)|soft_tissue(2)|haematopoietic_and_lymphoid_tissue(2)|prostate(2)|biliary_tract(1)|pituitary(1)											56.0	56.0	56.0					3																	178936082.0		1809.0	4069.0	5878.0	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	ENST00000263967.3:c.1624G>A	3.37:g.178936082G>A	ENSP00000263967:p.Glu542Lys		Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	34	5.360420	0.95877	.	.	ENSG00000121879	ENST00000263967	T	0.62105	0.05	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.69287	0.3094	L	0.41356	1.27	0.80722	D	1	D	0.65815	0.995	D	0.63192	0.912	T	0.60296	-0.7291	10	0.09843	T	0.71	-23.9623	20.0024	0.97423	0.0:0.0:1.0:0.0	.	542	P42336	PK3CA_HUMAN	K	542	ENSP00000263967:E542K	ENSP00000263967:E542K	E	+	1	0	PIK3CA	180418776	1.000000	0.71417	1.000000	0.80357	0.978000	0.69477	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAA	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000348409.2	2.424945	KEEP		+	10.002686	0.115385	6	46					40.24	3	6	32	30	0.333333	0.0	0.0	1	0	0	32.12	0.666667	1	0.00448238	0.00484795	0.307466	0	107	7922	236	53	8	7	0	0	0.0001706655	0.003	1	-3.108599	0.997858	1	1	1	1	0	52	280.0
PIK3R1	5295	broad.mit.edu	37	5	67522756	67522756	+	Missense_Mutation	SNP	C	C	T			AC-V11-Tumor-SM-9J467	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V11-Tumor-SM-9J467	none	g.chr5:67522756C>T	ENST00000521381.1	+	2	869	c.253C>T	c.(253-255)Ccc>Tcc	p.P85S	PIK3R1_ENST00000274335.5_Missense_Mutation_p.P85S|PIK3R1_ENST00000521657.1_Missense_Mutation_p.P85S|PIK3R1_ENST00000396611.1_Missense_Mutation_p.P85S	NM_181523.2	NP_852664.1	P27986	P85A_HUMAN	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	85.0					epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|growth hormone receptor signaling pathway|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|interspecies interaction between organisms|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of establishment of protein localization in plasma membrane|positive regulation of glucose import|T cell costimulation|T cell receptor signaling pathway	1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex	1-phosphatidylinositol binding|ErbB-3 class receptor binding|insulin binding|insulin receptor binding|insulin receptor substrate binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase regulator activity|protein phosphatase binding	p.0?(1)		breast(12)|central_nervous_system(31)|cervix(1)|endometrium(68)|haematopoietic_and_lymphoid_tissue(5)|kidney(1)|large_intestine(32)|lung(10)|ovary(9)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(2)	178.0		Lung NSC(167;1.99e-05)|Prostate(74;0.00308)|Ovarian(174;0.00473)|Colorectal(97;0.0176)		OV - Ovarian serous cystadenocarcinoma(47;3.76e-51)|Lung(70;0.0211)	Isoproterenol(DB01064)	AATCTCGCCTCCCACACCAAA	0.468			"""Mis, F, O"""		"""gliobastoma, ovarian, colorectal"""					TCGA GBM(4;<1E-08)																											Rec	yes		5	5q13.1	5295.0	"""phosphoinositide-3-kinase, regulatory subunit 1 (alpha)"""		"""E, O"""	1	Whole gene deletion(1)	large_intestine(1)											48.0	60.0	56.0					5																	67522756.0		2201.0	4300.0	6501.0	SO:0001583	missense			ENSG00000145675	HGNC:8979	NM_181504	Approved	uc003jva.3	ENST00000521381.1:c.253C>T	5.37:g.67522756C>T	ENSP00000428056:p.Pro85Ser		D3DWA0|Q15747|Q4VBZ7|Q53EM6|Q8IXA2|Q8N1C5	ENST00000521381.1	37	CCDS3993.1	.	.	.	.	.	.	.	.	.	.	C	29.0	4.967690	0.92855	.	.	ENSG00000145675	ENST00000521381;ENST00000521657;ENST00000396611;ENST00000274335	T;T;T;T	0.08282	3.11;3.11;3.11;3.11	5.77	5.77	0.91146	Src homology-3 domain (1);	0.000000	0.85682	D	0.000000	T	0.30039	0.0752	M	0.69823	2.125	0.80722	D	1	D	0.76494	0.999	D	0.70016	0.967	T	0.00073	-1.2125	10	0.39692	T	0.17	-13.3265	20.3473	0.98799	0.0:1.0:0.0:0.0	.	85	P27986	P85A_HUMAN	S	85	ENSP00000428056:P85S;ENSP00000429277:P85S;ENSP00000379855:P85S;ENSP00000274335:P85S	ENSP00000274335:P85S	P	+	1	0	PIK3R1	67558512	1.000000	0.71417	0.963000	0.40424	0.998000	0.95712	7.776000	0.85560	2.884000	0.98904	0.655000	0.94253	CCC	PIK3R1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000254013.2	186.791214	KEEP		+	188.541296	0.391813	67	104					43.4	32	39	50	61	0.549296	0.0	0.0	1	0	0	33.42	0.450704	1	1.34159e-35	2.02854e-35	1.0	0	48	7929	279	65	5	8	0	0	0.0001905756	0.003	1	-11.50248	0.9995555	1	1	1	1	0	171	0.0
PIK3R1	5295	broad.mit.edu	37	5	67522756	67522756	+	Missense_Mutation	SNP	C	C	T			AC-V11-Tumor-SM-9J468	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V11-Tumor-SM-9J468	none	g.chr5:67522756C>T	ENST00000521381.1	+	2	869	c.253C>T	c.(253-255)Ccc>Tcc	p.P85S	PIK3R1_ENST00000521657.1_Missense_Mutation_p.P85S|PIK3R1_ENST00000274335.5_Missense_Mutation_p.P85S|PIK3R1_ENST00000396611.1_Missense_Mutation_p.P85S	NM_181523.2	NP_852664.1	P27986	P85A_HUMAN	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	85.0					epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|growth hormone receptor signaling pathway|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|interspecies interaction between organisms|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of establishment of protein localization in plasma membrane|positive regulation of glucose import|T cell costimulation|T cell receptor signaling pathway	1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex	1-phosphatidylinositol binding|ErbB-3 class receptor binding|insulin binding|insulin receptor binding|insulin receptor substrate binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase regulator activity|protein phosphatase binding	p.0?(1)		breast(12)|central_nervous_system(31)|cervix(1)|endometrium(68)|haematopoietic_and_lymphoid_tissue(5)|kidney(1)|large_intestine(32)|lung(10)|ovary(9)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(2)	178.0		Lung NSC(167;1.99e-05)|Prostate(74;0.00308)|Ovarian(174;0.00473)|Colorectal(97;0.0176)		OV - Ovarian serous cystadenocarcinoma(47;3.76e-51)|Lung(70;0.0211)	Isoproterenol(DB01064)	AATCTCGCCTCCCACACCAAA	0.468			"""Mis, F, O"""		"""gliobastoma, ovarian, colorectal"""					TCGA GBM(4;<1E-08)																											Rec	yes		5.0	5q13.1	5295.0	"""phosphoinositide-3-kinase, regulatory subunit 1 (alpha)"""		"""E, O"""	1	Whole gene deletion(1)	large_intestine(1)											48.0	60.0	56.0					5																	67522756.0		2201.0	4300.0	6501.0	SO:0001583	missense			ENSG00000145675	HGNC:8979	NM_181504	Approved	uc003jva.3	ENST00000521381.1:c.253C>T	5.37:g.67522756C>T	ENSP00000428056:p.Pro85Ser		D3DWA0|Q15747|Q4VBZ7|Q53EM6|Q8IXA2|Q8N1C5	ENST00000521381.1	37	CCDS3993.1	.	.	.	.	.	.	.	.	.	.	C	29.0	4.967690	0.92855	.	.	ENSG00000145675	ENST00000521381;ENST00000521657;ENST00000396611;ENST00000274335	T;T;T;T	0.08282	3.11;3.11;3.11;3.11	5.77	5.77	0.91146	Src homology-3 domain (1);	0.000000	0.85682	D	0.000000	T	0.30039	0.0752	M	0.69823	2.125	0.80722	D	1	D	0.76494	0.999	D	0.70016	0.967	T	0.00073	-1.2125	10	0.39692	T	0.17	-13.3265	20.3473	0.98799	0.0:1.0:0.0:0.0	.	85	P27986	P85A_HUMAN	S	85	ENSP00000428056:P85S;ENSP00000429277:P85S;ENSP00000379855:P85S;ENSP00000274335:P85S	ENSP00000274335:P85S	P	+	1	0	PIK3R1	67558512	1.000000	0.71417	0.963000	0.40424	0.998000	0.95712	7.776000	0.85560	2.884000	0.98904	0.655000	0.94253	CCC	PIK3R1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000254013.2	10.247532	KEEP		+	18.452105	0.138462	9	56					41.42	4	5	40	23	0.555556	0.0	0.0	1	0	0	32.11	0.444444	1	1.12685e-05	1.32759e-05	0.307466	0	48	7929	279	65	5	8	0	0	0.0001697113	0.003	1	-3.075723	0.9970572	1	1	1	1	0	65	0.0
TP53	7157	broad.mit.edu	37	17	7578394	7578394	+	Missense_Mutation	SNP	T	T	A			AC-V12-Tumor-SM-9J46A	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V12-Tumor-SM-9J46A	none	g.chr17:7578394T>A	ENST00000420246.2	-	5	668	c.536A>T	c.(535-537)cAt>cTt	p.H179L	TP53_ENST00000269305.4_Missense_Mutation_p.H179L|TP53_ENST00000359597.4_Missense_Mutation_p.H179L|TP53_ENST00000413465.2_Missense_Mutation_p.H179L|TP53_ENST00000574684.1_5'UTR|TP53_ENST00000455263.2_Missense_Mutation_p.H179L|TP53_ENST00000445888.2_Missense_Mutation_p.H179L	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	179.0	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.		H -> D (in sporadic cancers; somatic mutation).|H -> L (in sporadic cancers; somatic mutation).|H -> N (in sporadic cancers; somatic mutation).|H -> P (in sporadic cancers; somatic mutation).|H -> Q (in sporadic cancers; somatic mutation).|H -> R (in sporadic cancers; somatic mutation).|H -> Y (in LFS; germline mutation and in sporadic cancers; somatic mutation).|HH -> QS (in a sporadic cancer; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.H179R(108)|p.H179L(43)|p.P177_C182delPHHERC(8)|p.0?(8)|p.H47L(4)|p.H86L(4)|p.C176_R181delCPHHER(3)|p.R174fs*24(3)|p.H179P(3)|p.H178_S183delHHERCS(3)|p.R175_E180delRCPHHE(3)|p.P177fs*3(2)|p.V173fs*59(2)|p.H86R(2)|p.H47R(2)|p.R174fs*1(2)|p.H179fs*68(1)|p.C176fs*65(1)|p.P177_H179delPHH(1)|p.V173fs*23(1)|p.V172_E180delVVRRCPHHE(1)|p.R174_H179delRRCPHH(1)|p.E171_H179delEVVRRCPHH(1)|p.R81fs*24(1)|p.R174_E180>K(1)|p.H46_S51delHHERCS(1)|p.H178fs*6(1)|p.P177_E180delPHHE(1)|p.R42fs*24(1)|p.H85_S90delHHERCS(1)|p.E171fs*1(1)|p.R174fs*3(1)|p.E171fs*61(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185.0		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GCAGCGCTCATGGTGGGGGCA	0.642		111.0	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)																									Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17.0	17p13	7157.0	tumor protein p53		"""L, E, M, O"""	217	Substitution - Missense(166)|Deletion - In frame(24)|Deletion - Frameshift(18)|Whole gene deletion(8)|Complex - deletion inframe(1)	lung(35)|breast(32)|large_intestine(29)|upper_aerodigestive_tract(26)|oesophagus(21)|ovary(21)|central_nervous_system(16)|haematopoietic_and_lymphoid_tissue(8)|urinary_tract(6)|pancreas(6)|liver(5)|bone(4)|biliary_tract(3)|cervix(1)|stomach(1)|endometrium(1)|salivary_gland(1)|skin(1)											47.0	47.0	47.0					17																	7578394.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	ENST00000420246.2:c.536A>T	17.37:g.7578394T>A	ENSP00000391127:p.His179Leu		Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	T	19.27	3.794677	0.70452	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99910	-7.88;-7.88;-7.88;-7.88;-7.88;-7.88;-7.88;-7.88	5.47	5.47	0.80525	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.048592	0.85682	D	0.000000	D	0.99917	0.9961	M	0.92507	3.315	0.80722	D	1	B;P;B;D;B;P;B	0.89917	0.081;0.679;0.133;1.0;0.333;0.536;0.224	B;P;B;D;P;B;B	0.97110	0.095;0.686;0.119;1.0;0.46;0.397;0.107	D	0.95915	0.8926	10	0.72032	D	0.01	-15.4889	13.8032	0.63214	0.0:0.0:0.0:1.0	.	140;179;179;86;179;179;179	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	L	179;179;179;179;179;179;168;86;47;86;47	ENSP00000410739:H179L;ENSP00000352610:H179L;ENSP00000269305:H179L;ENSP00000398846:H179L;ENSP00000391127:H179L;ENSP00000391478:H179L;ENSP00000425104:H47L;ENSP00000423862:H86L	ENSP00000269305:H179L	H	-	2	0	TP53	7519119	1.000000	0.71417	0.945000	0.38365	0.856000	0.48823	6.263000	0.72521	2.208000	0.71279	0.460000	0.39030	CAT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000367401.1	21.331489	KEEP		-	27.182944	0.2	14	56					48.4	6	12	34	35	0.333333	0.0	0.0	1	0	0	32.2		0	0.0	0.0	0.520397	0	54	8131	133	15	0	0	0	0	3.366262e-05	0.003	1	-20.0	1.0	1	1	1	1	0	70	2.0
MAPK1	5594	broad.mit.edu	37	22	22160227	22160227	+	Missense_Mutation	SNP	C	C	T			AC-V12-Tumor-SM-9J46A	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V12-Tumor-SM-9J46A	none	g.chr22:22160227C>T	ENST00000215832.6	-	3	592	c.404G>A	c.(403-405)aGa>aAa	p.R135K	MAPK1_ENST00000544786.1_Missense_Mutation_p.R135K|MAPK1_ENST00000398822.3_Missense_Mutation_p.R135K	NM_002745.4	NP_002736.3	P28482	MK01_HUMAN	mitogen-activated protein kinase 1	135.0	Protein kinase.				activation of MAPK activity|activation of MAPKK activity|axon guidance|cell cycle|epidermal growth factor receptor signaling pathway|ERK1 and ERK2 cascade|induction of apoptosis|innate immune response|insulin receptor signaling pathway|interspecies interaction between organisms|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|nerve growth factor receptor signaling pathway|platelet activation|Ras protein signal transduction|regulation of sequence-specific DNA binding transcription factor activity|stress-activated MAPK cascade|synaptic transmission|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|transcription, DNA-dependent	cytosol|nucleoplasm	ATP binding|DNA binding|MAP kinase activity|phosphatase binding|RNA polymerase II carboxy-terminal domain kinase activity			NS(1)|breast(1)|central_nervous_system(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(2)|ovary(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	17.0	Colorectal(54;0.105)	all_lung(157;3.89e-05)		READ - Rectum adenocarcinoma(21;0.0689)	Arsenic trioxide(DB01169)	TTTTAACCCTCTGAGGATCTG	0.448																																														0													203.0	187.0	193.0					22																	22160227.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000100030	HGNC:6871		Approved	uc002zvn.3	ENST00000215832.6:c.404G>A	22.37:g.22160227C>T	ENSP00000215832:p.Arg135Lys			ENST00000215832.6	37	CCDS13795.1	.	.	.	.	.	.	.	.	.	.	C	36	5.599358	0.96614	.	.	ENSG00000100030	ENST00000215832;ENST00000415911;ENST00000398822;ENST00000544786	T;T;T	0.64991	-0.13;-0.13;-0.13	4.77	4.77	0.60923	Serine/threonine-protein kinase-like domain (1);MAP kinase, conserved site (1);Serine/threonine-protein kinase, catalytic  domain (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);	0.000000	0.85682	D	0.000000	T	0.67496	0.2899	N	0.16602	0.42	0.80722	D	1	D;D	0.76494	0.993;0.999	D;D	0.80764	0.95;0.994	T	0.73594	-0.3933	10	0.87932	D	0	-2.875	18.343	0.90312	0.0:1.0:0.0:0.0	.	135;135	A8CZ64;P28482	.;MK01_HUMAN	K	135;123;135;135	ENSP00000215832:R135K;ENSP00000381803:R135K;ENSP00000440842:R135K	ENSP00000215832:R135K	R	-	2	0	MAPK1	20490227	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	7.563000	0.82314	2.637000	0.89404	0.650000	0.86243	AGA	MAPK1-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000075396.2	6.797006	KEEP		-	12.590633	0.145833	7	41					48.4	5	4	25	34	0.444444	0.0	0.0	1	0	0	32.2	0.555556	1	0.000274275	0.000295672	0.307466	0	46	8135	43	84	22	4	0	0	0.0002166127	0.003	1	-3.420386	0.9992196	1	1	1	1	0	48	1.0
TP53	7157	broad.mit.edu	37	17	7578394	7578394	+	Missense_Mutation	SNP	T	T	A			AC-V12-Tumor-SM-9N4BH	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V12-Tumor-SM-9N4BH	none	g.chr17:7578394T>A	ENST00000420246.2	-	5	668	c.536A>T	c.(535-537)cAt>cTt	p.H179L	TP53_ENST00000455263.2_Missense_Mutation_p.H179L|TP53_ENST00000269305.4_Missense_Mutation_p.H179L|TP53_ENST00000574684.1_5'UTR|TP53_ENST00000413465.2_Missense_Mutation_p.H179L|TP53_ENST00000359597.4_Missense_Mutation_p.H179L|TP53_ENST00000445888.2_Missense_Mutation_p.H179L	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	179.0	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.		H -> D (in sporadic cancers; somatic mutation).|H -> L (in sporadic cancers; somatic mutation).|H -> N (in sporadic cancers; somatic mutation).|H -> P (in sporadic cancers; somatic mutation).|H -> Q (in sporadic cancers; somatic mutation).|H -> R (in sporadic cancers; somatic mutation).|H -> Y (in LFS; germline mutation and in sporadic cancers; somatic mutation).|HH -> QS (in a sporadic cancer; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.H179R(108)|p.H179L(43)|p.P177_C182delPHHERC(8)|p.0?(8)|p.H47L(4)|p.H86L(4)|p.C176_R181delCPHHER(3)|p.R174fs*24(3)|p.H179P(3)|p.H178_S183delHHERCS(3)|p.R175_E180delRCPHHE(3)|p.P177fs*3(2)|p.V173fs*59(2)|p.H86R(2)|p.H47R(2)|p.R174fs*1(2)|p.H179fs*68(1)|p.C176fs*65(1)|p.P177_H179delPHH(1)|p.V173fs*23(1)|p.V172_E180delVVRRCPHHE(1)|p.R174_H179delRRCPHH(1)|p.E171_H179delEVVRRCPHH(1)|p.R81fs*24(1)|p.R174_E180>K(1)|p.H46_S51delHHERCS(1)|p.H178fs*6(1)|p.P177_E180delPHHE(1)|p.R42fs*24(1)|p.H85_S90delHHERCS(1)|p.E171fs*1(1)|p.R174fs*3(1)|p.E171fs*61(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185.0		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GCAGCGCTCATGGTGGGGGCA	0.642		111.0	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)																									Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17.0	17p13	7157.0	tumor protein p53		"""L, E, M, O"""	217	Substitution - Missense(166)|Deletion - In frame(24)|Deletion - Frameshift(18)|Whole gene deletion(8)|Complex - deletion inframe(1)	lung(35)|breast(32)|large_intestine(29)|upper_aerodigestive_tract(26)|oesophagus(21)|ovary(21)|central_nervous_system(16)|haematopoietic_and_lymphoid_tissue(8)|urinary_tract(6)|pancreas(6)|liver(5)|bone(4)|biliary_tract(3)|cervix(1)|stomach(1)|endometrium(1)|salivary_gland(1)|skin(1)											47.0	47.0	47.0					17																	7578394.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	ENST00000420246.2:c.536A>T	17.37:g.7578394T>A	ENSP00000391127:p.His179Leu		Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	T	19.27	3.794677	0.70452	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99910	-7.88;-7.88;-7.88;-7.88;-7.88;-7.88;-7.88;-7.88	5.47	5.47	0.80525	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.048592	0.85682	D	0.000000	D	0.99917	0.9961	M	0.92507	3.315	0.80722	D	1	B;P;B;D;B;P;B	0.89917	0.081;0.679;0.133;1.0;0.333;0.536;0.224	B;P;B;D;P;B;B	0.97110	0.095;0.686;0.119;1.0;0.46;0.397;0.107	D	0.95915	0.8926	10	0.72032	D	0.01	-15.4889	13.8032	0.63214	0.0:0.0:0.0:1.0	.	140;179;179;86;179;179;179	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	L	179;179;179;179;179;179;168;86;47;86;47	ENSP00000410739:H179L;ENSP00000352610:H179L;ENSP00000269305:H179L;ENSP00000398846:H179L;ENSP00000391127:H179L;ENSP00000391478:H179L;ENSP00000425104:H47L;ENSP00000423862:H86L	ENSP00000269305:H179L	H	-	2	0	TP53	7519119	1.000000	0.71417	0.945000	0.38365	0.856000	0.48823	6.263000	0.72521	2.208000	0.71279	0.460000	0.39030	CAT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000367401.1	77.468453	KEEP		-	77.468453	0.5	29	29					45.05	14	24	19	18	0.368421	0.0	0.0	1	0	0	29.05		0	0.0	0.0	0.017118	0	54	8131	133	15	0	0	0	0	4.341164e-05	0.003	1	-20.0	1.0	1	1	1	1	0	58	2.0
MTOR	2475	broad.mit.edu	37	1	11168265	11168265	+	Missense_Mutation	SNP	T	T	G			AC-V14-Tumor-SM-9J46C	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V14-Tumor-SM-9J46C	none	g.chr1:11168265T>G	ENST00000361445.4	-	57	7683	c.7607A>C	c.(7606-7608)gAa>gCa	p.E2536A	MTOR_ENST00000376838.1_Missense_Mutation_p.E741A	NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	2536.0	FATC.				cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						GCAGAGGTTTTCATGGGATGT	0.483																																														0													114.0	102.0	106.0					1																	11168265.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.7607A>C	1.37:g.11168265T>G	ENSP00000354558:p.Glu2536Ala		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37	CCDS127.1	.	.	.	.	.	.	.	.	.	.	T	31	5.085596	0.94100	.	.	ENSG00000198793	ENST00000361445;ENST00000376838	T;T	0.79653	-1.29;-1.29	5.53	5.53	0.82687	PIK-related kinase, FATC (2);Phosphatidylinositol 3-/4-kinase, catalytic (2);	0.000000	0.85682	D	0.000000	D	0.89220	0.6653	M	0.85099	2.735	0.80722	D	1	D	0.58970	0.984	P	0.59948	0.866	D	0.90778	0.4677	10	0.66056	D	0.02	-15.8206	15.1268	0.72489	0.0:0.0:0.0:1.0	.	2536	P42345	MTOR_HUMAN	A	2536;741	ENSP00000354558:E2536A;ENSP00000366034:E741A	ENSP00000354558:E2536A	E	-	2	0	MTOR	11090852	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	7.423000	0.80229	2.226000	0.72624	0.459000	0.35465	GAA	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	-11.668912	KEEP		-	6.37626	0.08	8	92					46.97	0	8	53	57	0.0	0.0	0.0	1	0	0	33.89		0	0.0	0.0	1.0	0	47	8178	82	24	2	0	0	0	3.638425e-05	0.003	1	-6.083484	1.0	1	1	1	1	0	100	0.0
KMT2A	4297	broad.mit.edu	37	11	118375218	118375218	+	Missense_Mutation	SNP	G	G	A			AC-V15-Tumor-SM-9J46E	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46E	none	g.chr11:118375218G>A	ENST00000534358.1	+	27	8634	c.8611G>A	c.(8611-8613)Gag>Aag	p.E2871K	KMT2A_ENST00000354520.4_Missense_Mutation_p.E2830K|KMT2A_ENST00000389506.5_Missense_Mutation_p.E2868K	NM_001197104.1|NM_005933.3	NP_001184033.1|NP_005924.2			lysine (K)-specific methyltransferase 2A																		TGAGAGCCCAGAGTCATCTTC	0.423																																														0													134.0	126.0	129.0					11																	118375218.0		2200.0	4295.0	6495.0	SO:0001583	missense			ENSG00000118058	HGNC:7132	NM_005933	Approved		ENST00000534358.1:c.8611G>A	11.37:g.118375218G>A	ENSP00000436786:p.Glu2871Lys			ENST00000534358.1	37	CCDS55791.1	.	.	.	.	.	.	.	.	.	.	G	17.33	3.362638	0.61403	.	.	ENSG00000118058	ENST00000534358;ENST00000389506;ENST00000354520;ENST00000359313	D;D;D	0.88201	-2.35;-2.35;-2.29	6.06	6.06	0.98353	.	0.000000	0.85682	D	0.000000	D	0.93077	0.7796	L	0.48642	1.525	0.80722	D	1	D;D	0.69078	0.997;0.997	D;D	0.75020	0.985;0.985	D	0.92908	0.6345	10	0.87932	D	0	.	20.6282	0.99521	0.0:0.0:1.0:0.0	.	2871;2868	E9PQG7;Q03164	.;MLL1_HUMAN	K	2871;2868;2830;1778	ENSP00000436786:E2871K;ENSP00000374157:E2868K;ENSP00000346516:E2830K	ENSP00000346516:E2830K	E	+	1	0	MLL	117880428	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.352000	0.97076	2.871000	0.98454	0.655000	0.94253	GAG	KMT2A-001	NOVEL	basic|appris_candidate_longest|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000389228.2	18.534646	KEEP		+	20.297983	0.27027	10	27					41.7	6	6	6	24	0.5	0.0	0.0	1	0	0	32.62	0.5	1	3.07112e-06	3.83652e-06	0.38729	0	46	8105	89	61	30	3	0	0	0.0002764284	0.003	1	-4.357695	0.9996702	1	1	1	1	0	37	0.0
KMT2D	8085	broad.mit.edu	37	12	49428202	49428202	+	Nonsense_Mutation	SNP	C	C	A			AC-V15-Tumor-SM-9J46E	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46E	none	g.chr12:49428202C>A	ENST00000301067.7	-	37	10497	c.10498G>T	c.(10498-10500)Gga>Tga	p.G3500*		NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D																		CTGATCACTCCCTGAGCAAAA	0.572																																														0													42.0	46.0	45.0					12																	49428202.0		1956.0	4157.0	6113.0	SO:0001587	stop_gained			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.10498G>T	12.37:g.49428202C>A	ENSP00000301067:p.Gly3500*			ENST00000301067.7	37	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	C	52	19.434737	0.99919	.	.	ENSG00000167548	ENST00000301067	.	.	.	5.51	4.62	0.57501	.	0.000000	0.37530	N	0.002051	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	15.751	0.77986	0.0:0.863:0.137:0.0	.	.	.	.	X	3500	.	ENSP00000301067:G3500X	G	-	1	0	MLL2	47714469	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	7.305000	0.78891	1.485000	0.48380	0.655000	0.94253	GGA	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	21.269888	KEEP		-	21.313342	0.45	9	11					41.7	5	8	8	6	0.615385	0.00010058	0.000102788	1	1	0	32.62	0.384615	0	0.0	0.0	0.411799	0	98	7962	240	30	2	2	0	0	0.0001064781	0.003	1	-6.00994	0.999997	1	1	1	1	0	20	0.0
FBXW7	0	broad.mit.edu	37	4	153249393	153249393	+	Missense_Mutation	SNP	G	G	T			AC-V15-Tumor-SM-9J46E	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46E	none	g.chr4:153249393G>T	ENST00000281708.4	-	9	2614	c.1385C>A	c.(1384-1386)tCc>tAc	p.S462Y	FBXW7_ENST00000263981.5_Missense_Mutation_p.S382Y|FBXW7_ENST00000393956.3_Missense_Mutation_p.S286Y|FBXW7_ENST00000603548.1_Missense_Mutation_p.S462Y|FBXW7_ENST00000603841.1_Missense_Mutation_p.S462Y|FBXW7_ENST00000296555.5_Missense_Mutation_p.S344Y	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	462.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				ACGCACAGTGGAAGTATGCCC	0.413			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4.0	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	1	Unknown(1)	haematopoietic_and_lymphoid_tissue(1)											276.0	235.0	249.0					4																	153249393.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1385C>A	4.37:g.153249393G>T	ENSP00000281708:p.Ser462Tyr		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	26.3	4.727822	0.89390	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.47528	0.84;0.84;0.84;0.84	6.05	6.05	0.98169	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	T	0.69296	0.3095	M	0.64080	1.96	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.68792	-0.5315	10	0.87932	D	0	-7.4364	20.6013	0.99457	0.0:0.0:1.0:0.0	.	286;462;344;382	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	Y	462;344;382;286	ENSP00000281708:S462Y;ENSP00000296555:S344Y;ENSP00000263981:S382Y;ENSP00000377528:S286Y	ENSP00000263981:S382Y	S	-	2	0	FBXW7	153468843	1.000000	0.71417	0.999000	0.59377	0.996000	0.88848	9.869000	0.99810	2.878000	0.98634	0.650000	0.86243	TCC	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	9.709224	KEEP		-	13.476834	0.179487	7	32					41.7	1	8	18	19	0.111111	5.68852e-11	5.96187e-11	1	1	0	32.62	0.888889	0	0.0	0.0	0.307466	0	45	8160	48	52	26	3	0	0	0.0002329472	0.003	1	-3.693158	0.9998039	1	1	1	1	0	39	0.0
FBXW7	0	broad.mit.edu	37	4	153245521	153245521	+	Missense_Mutation	SNP	C	C	T			AC-V15-Tumor-SM-9J46E	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46E	none	g.chr4:153245521C>T	ENST00000281708.4	-	11	2899	c.1670G>A	c.(1669-1671)gGa>gAa	p.G557E	FBXW7_ENST00000263981.5_Missense_Mutation_p.G477E|FBXW7_ENST00000393956.3_Missense_Mutation_p.G381E|FBXW7_ENST00000603548.1_Missense_Mutation_p.G557E|FBXW7_ENST00000603841.1_Missense_Mutation_p.G557E|FBXW7_ENST00000296555.5_Missense_Mutation_p.G439E	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	557.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				ATCAAGAGATCCACTCACCAC	0.403			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4.0	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	1	Unknown(1)	haematopoietic_and_lymphoid_tissue(1)											113.0	85.0	95.0					4																	153245521.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1670G>A	4.37:g.153245521C>T	ENSP00000281708:p.Gly557Glu		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	C	29.9	5.044441	0.93685	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.73789	-0.78;-0.78;-0.78;-0.78	5.61	5.61	0.85477	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40 repeat, conserved site (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	D	0.92074	0.7488	H	0.97962	4.115	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	D	0.94613	0.7806	10	0.87932	D	0	-17.8778	19.6375	0.95740	0.0:1.0:0.0:0.0	.	381;557;439;477	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	E	557;439;477;381	ENSP00000281708:G557E;ENSP00000296555:G439E;ENSP00000263981:G477E;ENSP00000377528:G381E	ENSP00000263981:G477E	G	-	2	0	FBXW7	153464971	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.818000	0.86416	2.640000	0.89533	0.655000	0.94253	GGA	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	17.336645	KEEP		-	20.150081	0.232558	10	33					41.7	8	4	19	18	0.333333	0.0	0.0	1	0	0	32.62	0.666667	1	0.000978159	0.00108133	0.38729	0	380	7788	142	23	0	0	0	0	3.853074e-05	0.003	1	-19.87211	1.0	1	1	1	1	0	43	0.0
BRCA2	675	broad.mit.edu	37	13	32968975	32968975	+	Missense_Mutation	SNP	C	C	G	rs80359761		AC-V15-Tumor-SM-9J46E	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46E	none	g.chr13:32968975C>G	ENST00000544455.1	+	25	9633	c.9406C>G	c.(9406-9408)Ctt>Gtt	p.L3136V	BRCA2_ENST00000380152.3_Missense_Mutation_p.L3136V	NM_000059.3	NP_000050	P51587	BRCA2_HUMAN	breast cancer 2, early onset	3136.0					cell cycle cytokinesis|centrosome duplication|double-strand break repair via homologous recombination|negative regulation of mammary gland epithelial cell proliferation|nucleotide-excision repair|positive regulation of transcription, DNA-dependent|regulation of S phase of mitotic cell cycle	BRCA2-MAGE-D1 complex|centrosome|nucleoplasm|stored secretory granule	gamma-tubulin binding|H3 histone acetyltransferase activity|H4 histone acetyltransferase activity|protease binding|single-stranded DNA binding			NS(3)|breast(13)|central_nervous_system(5)|cervix(2)|endometrium(24)|haematopoietic_and_lymphoid_tissue(1)|kidney(10)|large_intestine(32)|liver(1)|lung(41)|oesophagus(5)|ovary(22)|pancreas(4)|prostate(3)|salivary_gland(1)|skin(11)|upper_aerodigestive_tract(2)|urinary_tract(3)	183.0		Lung SC(185;0.0262)		all cancers(112;7.13e-07)|Epithelial(112;1.59e-05)|OV - Ovarian serous cystadenocarcinoma(117;0.000732)|BRCA - Breast invasive adenocarcinoma(63;0.0291)|GBM - Glioblastoma multiforme(144;0.0704)		ATCAGGCCTTCTTACTTTATT	0.378			"""D, Mis, N, F, S"""		"""breast, ovarian, pancreatic"""	"""breast, ovarian, pancreatic, leukemia  (FANCB, FANCD1)"""		Homologous recombination	Pancreatic Cancer, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Prostate Cancer;Hereditary Breast-Ovarian Cancer, BRCA2 type;Fanconi Anemia type D1, bi-allelic BRCA2 mutations;Fanconi Anemia	TCGA Ovarian(8;0.087)																									Esophageal Squamous(138;838 1285 7957 30353 30468 36915 49332)	yes	Rec	yes	Hereditary breast/ovarian cancer	13.0	13q12	675.0	familial breast/ovarian cancer gene 2		"""L, E"""	0													95.0	89.0	91.0					13																	32968975.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	incl.: Hereditary Pancreatic Adenocarcinoma, Insulin-Dependent Diabetes Mellitus - Exocrine Insufficiency - Familial Pancreatic Cancer, PNCA1;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;HPC; ;FANCD1;Pancytopenia Dysmelia, FA (several complementation groups)	ENSG00000139618	HGNC:1101	NM_000059	Approved	uc001uub.1	ENST00000544455.1:c.9406C>G	13.37:g.32968975C>G	ENSP00000439902:p.Leu3136Val		O00183|O15008|Q13879|Q5TBJ7	ENST00000544455.1	37	CCDS9344.1	.	.	.	.	.	.	.	.	.	.	C	14.36	2.511193	0.44660	.	.	ENSG00000139618	ENST00000380152;ENST00000544455	T;T	0.80824	-1.42;-1.42	5.89	5.04	0.67666	Nucleic acid-binding, OB-fold-like (1);BRCA2, oligonucleotide/oligosaccharide-binding 3 (1);	0.163476	0.56097	D	0.000035	T	0.63604	0.2525	N	0.08118	0	0.22034	N	0.999405	B	0.06786	0.001	B	0.04013	0.001	T	0.54649	-0.8262	10	0.41790	T	0.15	.	12.7621	0.57370	0.0:0.925:0.0:0.075	.	3136	P51587	BRCA2_HUMAN	V	3136	ENSP00000369497:L3136V;ENSP00000439902:L3136V	ENSP00000369497:L3136V	L	+	1	0	BRCA2	31866975	1.000000	0.71417	0.993000	0.49108	0.802000	0.45316	3.498000	0.53302	2.788000	0.95919	0.557000	0.71058	CTT	BRCA2-201	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding		45.702189	KEEP		+	50.74384	0.252747	23	68					41.7	9	18	49	34	0.666667	0.0	0.0	1	0	0	32.62	0.333333	0	0.0	0.0	0.667858	0	47	8095	167	20	2	3	0	0	8.179749e-05	0.003	1	-4.467706	0.9999987	1	1	1	1	0	91	0.0
FBXW7	0	broad.mit.edu	37	4	153249393	153249393	+	Missense_Mutation	SNP	G	G	T			AC-V15-Tumor-SM-9J46F	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46F	none	g.chr4:153249393G>T	ENST00000281708.4	-	9	2614	c.1385C>A	c.(1384-1386)tCc>tAc	p.S462Y	FBXW7_ENST00000296555.5_Missense_Mutation_p.S344Y|FBXW7_ENST00000603548.1_Missense_Mutation_p.S462Y|FBXW7_ENST00000263981.5_Missense_Mutation_p.S382Y|FBXW7_ENST00000393956.3_Missense_Mutation_p.S286Y|FBXW7_ENST00000603841.1_Missense_Mutation_p.S462Y	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	462.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				ACGCACAGTGGAAGTATGCCC	0.413			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4.0	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	1	Unknown(1)	haematopoietic_and_lymphoid_tissue(1)											276.0	235.0	249.0					4																	153249393.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1385C>A	4.37:g.153249393G>T	ENSP00000281708:p.Ser462Tyr		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	26.3	4.727822	0.89390	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.47528	0.84;0.84;0.84;0.84	6.05	6.05	0.98169	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	T	0.69296	0.3095	M	0.64080	1.96	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.68792	-0.5315	10	0.87932	D	0	-7.4364	20.6013	0.99457	0.0:0.0:1.0:0.0	.	286;462;344;382	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	Y	462;344;382;286	ENSP00000281708:S462Y;ENSP00000296555:S344Y;ENSP00000263981:S382Y;ENSP00000377528:S286Y	ENSP00000263981:S382Y	S	-	2	0	FBXW7	153468843	1.000000	0.71417	0.999000	0.59377	0.996000	0.88848	9.869000	0.99810	2.878000	0.98634	0.650000	0.86243	TCC	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	7.401325	KEEP		-	8.672061	0.222222	4	14					46.8	4	1	9	6	0.8	0.184627	0.185146	1	1	0	32.89	0.2	0	0.0	0.0	0.184627	0	45	8160	48	52	26	3	0	0	0.0002340275	0.003	1	-3.927548	0.9998693	1	1	1	1	0	18	0.0
KMT2A	4297	broad.mit.edu	37	11	118375218	118375218	+	Missense_Mutation	SNP	G	G	A			AC-V15-Tumor-SM-9J46F	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46F	none	g.chr11:118375218G>A	ENST00000534358.1	+	27	8634	c.8611G>A	c.(8611-8613)Gag>Aag	p.E2871K	KMT2A_ENST00000389506.5_Missense_Mutation_p.E2868K|KMT2A_ENST00000354520.4_Missense_Mutation_p.E2830K	NM_001197104.1|NM_005933.3	NP_001184033.1|NP_005924.2			lysine (K)-specific methyltransferase 2A																		TGAGAGCCCAGAGTCATCTTC	0.423																																														0													134.0	126.0	129.0					11																	118375218.0		2200.0	4295.0	6495.0	SO:0001583	missense			ENSG00000118058	HGNC:7132	NM_005933	Approved		ENST00000534358.1:c.8611G>A	11.37:g.118375218G>A	ENSP00000436786:p.Glu2871Lys			ENST00000534358.1	37	CCDS55791.1	.	.	.	.	.	.	.	.	.	.	G	17.33	3.362638	0.61403	.	.	ENSG00000118058	ENST00000534358;ENST00000389506;ENST00000354520;ENST00000359313	D;D;D	0.88201	-2.35;-2.35;-2.29	6.06	6.06	0.98353	.	0.000000	0.85682	D	0.000000	D	0.93077	0.7796	L	0.48642	1.525	0.80722	D	1	D;D	0.69078	0.997;0.997	D;D	0.75020	0.985;0.985	D	0.92908	0.6345	10	0.87932	D	0	.	20.6282	0.99521	0.0:0.0:1.0:0.0	.	2871;2868	E9PQG7;Q03164	.;MLL1_HUMAN	K	2871;2868;2830;1778	ENSP00000436786:E2871K;ENSP00000374157:E2868K;ENSP00000346516:E2830K	ENSP00000346516:E2830K	E	+	1	0	MLL	117880428	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.352000	0.97076	2.871000	0.98454	0.655000	0.94253	GAG	KMT2A-001	NOVEL	basic|appris_candidate_longest|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000389228.2	8.337689	KEEP		+	10.853982	0.2	6	24					46.8	5	1	16	13	0.833333	0.0	0.0	1	0	0	32.89	0.166667	1	5.9392e-07	7.88214e-07	0.217242	0	46	8105	89	61	30	3	0	0	0.0002737783	0.003	1	-3.811077	0.9994249	1	1	1	1	0	30	0.0
FBXW7	0	broad.mit.edu	37	4	153245521	153245521	+	Missense_Mutation	SNP	C	C	T			AC-V15-Tumor-SM-9J46F	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V15-Tumor-SM-9J46F	none	g.chr4:153245521C>T	ENST00000281708.4	-	11	2899	c.1670G>A	c.(1669-1671)gGa>gAa	p.G557E	FBXW7_ENST00000296555.5_Missense_Mutation_p.G439E|FBXW7_ENST00000603548.1_Missense_Mutation_p.G557E|FBXW7_ENST00000263981.5_Missense_Mutation_p.G477E|FBXW7_ENST00000393956.3_Missense_Mutation_p.G381E|FBXW7_ENST00000603841.1_Missense_Mutation_p.G557E	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	557.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				ATCAAGAGATCCACTCACCAC	0.403			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4.0	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	1	Unknown(1)	haematopoietic_and_lymphoid_tissue(1)											113.0	85.0	95.0					4																	153245521.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1670G>A	4.37:g.153245521C>T	ENSP00000281708:p.Gly557Glu		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	C	29.9	5.044441	0.93685	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.73789	-0.78;-0.78;-0.78;-0.78	5.61	5.61	0.85477	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40 repeat, conserved site (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	D	0.92074	0.7488	H	0.97962	4.115	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	D	0.94613	0.7806	10	0.87932	D	0	-17.8778	19.6375	0.95740	0.0:1.0:0.0:0.0	.	381;557;439;477	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	E	557;439;477;381	ENSP00000281708:G557E;ENSP00000296555:G439E;ENSP00000263981:G477E;ENSP00000377528:G381E	ENSP00000263981:G477E	G	-	2	0	FBXW7	153464971	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.818000	0.86416	2.640000	0.89533	0.655000	0.94253	GGA	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	5.868493	KEEP		-	9.470689	0.15625	5	27					46.8	3	2	18	16	0.4	0.0	0.0	1	0	0	32.89	0.6	1	0.014758	0.0159172	0.184627	0	380	7788	142	23	0	0	0	0	3.617735e-05	0.003	1	-11.67898	1.0	1	1	1	1	0	32	0.0
ARID2	196528	broad.mit.edu	37	12	46231467	46231467	+	Missense_Mutation	SNP	T	T	A			AC-V16-Tumor-SM-9J46G	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V16-Tumor-SM-9J46G	none	g.chr12:46231467T>A	ENST00000334344.6	+	10	1479	c.1307T>A	c.(1306-1308)aTt>aAt	p.I436N	ARID2_ENST00000444670.1_Missense_Mutation_p.I65N|ARID2_ENST00000479608.1_3'UTR|ARID2_ENST00000422737.1_Missense_Mutation_p.I287N	NM_152641.2	NP_689854.2	Q68CP9	ARID2_HUMAN	AT rich interactive domain 2 (ARID, RFX-like)	436.0					chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|protein binding|zinc ion binding			NS(1)|autonomic_ganglia(1)|breast(7)|central_nervous_system(3)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(21)|liver(20)|lung(34)|ovary(7)|pancreas(1)|prostate(2)|skin(5)|stomach(1)|upper_aerodigestive_tract(2)	116.0	Lung SC(27;0.192)|Renal(347;0.236)	Lung NSC(34;0.106)|all_lung(34;0.22)	OV - Ovarian serous cystadenocarcinoma(5;0.00691)	GBM - Glioblastoma multiforme(48;0.0153)		TGCACAAAAATTGCAAAAGTA	0.363			"""N, S, F"""		hepatocellular carcinoma																																Rec	yes		12.0	12q12	196528.0	AT rich interactive domain 2		E	0													98.0	90.0	93.0					12																	46231467.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000189079	HGNC:18037	XM_350875	Approved	uc001ros.1	ENST00000334344.6:c.1307T>A	12.37:g.46231467T>A	ENSP00000335044:p.Ile436Asn		Q15KG9|Q5EB51|Q645I3|Q6ZRY5|Q7Z3I5|Q86T28|Q96SJ6|Q9HCL5	ENST00000334344.6	37	CCDS31783.1	.	.	.	.	.	.	.	.	.	.	T	19.46	3.831796	0.71258	.	.	ENSG00000189079	ENST00000334344;ENST00000422737;ENST00000444670	T;T	0.53206	0.63;0.63	5.12	5.12	0.69794	.	0.058120	0.64402	D	0.000003	T	0.66187	0.2764	M	0.66939	2.045	0.80722	D	1	D;D;D	0.71674	0.998;0.998;0.998	D;D;P	0.70227	0.962;0.968;0.896	T	0.70454	-0.4867	10	0.87932	D	0	-12.093	14.9182	0.70815	0.0:0.0:0.0:1.0	.	436;287;436	Q68CP9-3;F8WCU9;Q68CP9	.;.;ARID2_HUMAN	N	436;287;65	ENSP00000335044:I436N;ENSP00000415650:I287N	ENSP00000335044:I436N	I	+	2	0	ARID2	44517734	1.000000	0.71417	1.000000	0.80357	0.884000	0.51177	8.008000	0.88588	1.926000	0.55796	0.260000	0.18958	ATT	ARID2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000318380.2	14.318336	KEEP		+	17.920493	0.212766	10	37					42.96	5	6	22	17	0.454545	0.0	0.0	1	0	0	34.83		0	0.0	0.0	1.0	0	48	8113	154	18	0	0	0	0	3.954549e-05	0.003	1	-19.74936	1.0	1	1	1	1	0	47	0.0
ARID2	196528	broad.mit.edu	37	12	46244283	46244283	+	Nonsense_Mutation	SNP	C	C	T			AC-V16-Tumor-SM-9J46G	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V16-Tumor-SM-9J46G	none	g.chr12:46244283C>T	ENST00000334344.6	+	15	2549	c.2377C>T	c.(2377-2379)Caa>Taa	p.Q793*	ARID2_ENST00000444670.1_Nonsense_Mutation_p.Q403*|ARID2_ENST00000479608.1_3'UTR|ARID2_ENST00000422737.1_Nonsense_Mutation_p.Q644*	NM_152641.2	NP_689854.2	Q68CP9	ARID2_HUMAN	AT rich interactive domain 2 (ARID, RFX-like)	793.0	Gln-rich.				chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|protein binding|zinc ion binding			NS(1)|autonomic_ganglia(1)|breast(7)|central_nervous_system(3)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(21)|liver(20)|lung(34)|ovary(7)|pancreas(1)|prostate(2)|skin(5)|stomach(1)|upper_aerodigestive_tract(2)	116.0	Lung SC(27;0.192)|Renal(347;0.236)	Lung NSC(34;0.106)|all_lung(34;0.22)	OV - Ovarian serous cystadenocarcinoma(5;0.00691)	GBM - Glioblastoma multiforme(48;0.0153)		TACAGTAATTCAACAAGCTGT	0.453			"""N, S, F"""		hepatocellular carcinoma																																Rec	yes		12.0	12q12	196528.0	AT rich interactive domain 2		E	0													91.0	80.0	84.0					12																	46244283.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained			ENSG00000189079	HGNC:18037	XM_350875	Approved	uc001ros.1	ENST00000334344.6:c.2377C>T	12.37:g.46244283C>T	ENSP00000335044:p.Gln793*		Q15KG9|Q5EB51|Q645I3|Q6ZRY5|Q7Z3I5|Q86T28|Q96SJ6|Q9HCL5	ENST00000334344.6	37	CCDS31783.1	.	.	.	.	.	.	.	.	.	.	C	41	8.614297	0.98886	.	.	ENSG00000189079	ENST00000334344;ENST00000422737;ENST00000444670	.	.	.	5.83	5.83	0.93111	.	0.049507	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.24483	T	0.36	-4.521	20.1152	0.97926	0.0:1.0:0.0:0.0	.	.	.	.	X	793;644;403	.	ENSP00000335044:Q793X	Q	+	1	0	ARID2	44530550	1.000000	0.71417	0.998000	0.56505	0.993000	0.82548	6.776000	0.75023	2.750000	0.94351	0.655000	0.94253	CAA	ARID2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000318380.2	14.089333	KEEP		+	15.565	0.266667	8	22					42.96	5	4	16	7	0.444444	0.0	0.0	1	0	0	34.83	0.555556	1	0.000274275	0.000305735	1.0	0	50	7960	291	30	2	0	0	0	9.183297e-05	0.003	1	-10.2819	0.9999937	1	1	1	1	0	30	0.0
ARID2	196528	broad.mit.edu	37	12	46231467	46231467	+	Missense_Mutation	SNP	T	T	A			AC-V16-Tumor-SM-9J46H	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V16-Tumor-SM-9J46H	none	g.chr12:46231467T>A	ENST00000334344.6	+	10	1479	c.1307T>A	c.(1306-1308)aTt>aAt	p.I436N	ARID2_ENST00000479608.1_3'UTR|ARID2_ENST00000422737.1_Missense_Mutation_p.I287N|ARID2_ENST00000444670.1_Missense_Mutation_p.I65N	NM_152641.2	NP_689854.2	Q68CP9	ARID2_HUMAN	AT rich interactive domain 2 (ARID, RFX-like)	436.0					chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|protein binding|zinc ion binding			NS(1)|autonomic_ganglia(1)|breast(7)|central_nervous_system(3)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(21)|liver(20)|lung(34)|ovary(7)|pancreas(1)|prostate(2)|skin(5)|stomach(1)|upper_aerodigestive_tract(2)	116.0	Lung SC(27;0.192)|Renal(347;0.236)	Lung NSC(34;0.106)|all_lung(34;0.22)	OV - Ovarian serous cystadenocarcinoma(5;0.00691)	GBM - Glioblastoma multiforme(48;0.0153)		TGCACAAAAATTGCAAAAGTA	0.363			"""N, S, F"""		hepatocellular carcinoma																																Rec	yes		12.0	12q12	196528.0	AT rich interactive domain 2		E	0													98.0	90.0	93.0					12																	46231467.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000189079	HGNC:18037	XM_350875	Approved	uc001ros.1	ENST00000334344.6:c.1307T>A	12.37:g.46231467T>A	ENSP00000335044:p.Ile436Asn		Q15KG9|Q5EB51|Q645I3|Q6ZRY5|Q7Z3I5|Q86T28|Q96SJ6|Q9HCL5	ENST00000334344.6	37	CCDS31783.1	.	.	.	.	.	.	.	.	.	.	T	19.46	3.831796	0.71258	.	.	ENSG00000189079	ENST00000334344;ENST00000422737;ENST00000444670	T;T	0.53206	0.63;0.63	5.12	5.12	0.69794	.	0.058120	0.64402	D	0.000003	T	0.66187	0.2764	M	0.66939	2.045	0.80722	D	1	D;D;D	0.71674	0.998;0.998;0.998	D;D;P	0.70227	0.962;0.968;0.896	T	0.70454	-0.4867	10	0.87932	D	0	-12.093	14.9182	0.70815	0.0:0.0:0.0:1.0	.	436;287;436	Q68CP9-3;F8WCU9;Q68CP9	.;.;ARID2_HUMAN	N	436;287;65	ENSP00000335044:I436N;ENSP00000415650:I287N	ENSP00000335044:I436N	I	+	2	0	ARID2	44517734	1.000000	0.71417	1.000000	0.80357	0.884000	0.51177	8.008000	0.88588	1.926000	0.55796	0.260000	0.18958	ATT	ARID2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000318380.2	123.517365	KEEP		+	128.605116	0.315476	53	115					42.33	22	38	57	69	0.366667	0.0	0.0	1	0	0	31.01		0	0.0	0.0	0.139131	0	48	8113	154	18	0	0	0	0	4.313796e-05	0.003	1	-20.0	1.0	1	1	1	1	0	168	0.0
ARID2	196528	broad.mit.edu	37	12	46244283	46244283	+	Nonsense_Mutation	SNP	C	C	T			AC-V16-Tumor-SM-9J46H	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V16-Tumor-SM-9J46H	none	g.chr12:46244283C>T	ENST00000334344.6	+	15	2549	c.2377C>T	c.(2377-2379)Caa>Taa	p.Q793*	ARID2_ENST00000479608.1_3'UTR|ARID2_ENST00000422737.1_Nonsense_Mutation_p.Q644*|ARID2_ENST00000444670.1_Nonsense_Mutation_p.Q403*	NM_152641.2	NP_689854.2	Q68CP9	ARID2_HUMAN	AT rich interactive domain 2 (ARID, RFX-like)	793.0	Gln-rich.				chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|protein binding|zinc ion binding			NS(1)|autonomic_ganglia(1)|breast(7)|central_nervous_system(3)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(21)|liver(20)|lung(34)|ovary(7)|pancreas(1)|prostate(2)|skin(5)|stomach(1)|upper_aerodigestive_tract(2)	116.0	Lung SC(27;0.192)|Renal(347;0.236)	Lung NSC(34;0.106)|all_lung(34;0.22)	OV - Ovarian serous cystadenocarcinoma(5;0.00691)	GBM - Glioblastoma multiforme(48;0.0153)		TACAGTAATTCAACAAGCTGT	0.453			"""N, S, F"""		hepatocellular carcinoma																																Rec	yes		12.0	12q12	196528.0	AT rich interactive domain 2		E	0													91.0	80.0	84.0					12																	46244283.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained			ENSG00000189079	HGNC:18037	XM_350875	Approved	uc001ros.1	ENST00000334344.6:c.2377C>T	12.37:g.46244283C>T	ENSP00000335044:p.Gln793*		Q15KG9|Q5EB51|Q645I3|Q6ZRY5|Q7Z3I5|Q86T28|Q96SJ6|Q9HCL5	ENST00000334344.6	37	CCDS31783.1	.	.	.	.	.	.	.	.	.	.	C	41	8.614297	0.98886	.	.	ENSG00000189079	ENST00000334344;ENST00000422737;ENST00000444670	.	.	.	5.83	5.83	0.93111	.	0.049507	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.24483	T	0.36	-4.521	20.1152	0.97926	0.0:1.0:0.0:0.0	.	.	.	.	X	793;644;403	.	ENSP00000335044:Q793X	Q	+	1	0	ARID2	44530550	1.000000	0.71417	0.998000	0.56505	0.993000	0.82548	6.776000	0.75023	2.750000	0.94351	0.655000	0.94253	CAA	ARID2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000318380.2	73.466388	KEEP		+	78.445294	0.286885	35	87					42.33	25	14	40	51	0.358974	0.0	0.0	1	0	0	31.01	0.641026	1	1.56738e-10	1.93832e-10	0.203993	0	50	7960	291	30	2	0	0	0	9.318213e-05	0.003	1	-20.0	0.9999945	1	1	1	1	0	122	0.0
CASP8	841	broad.mit.edu	37	2	202150003	202150003	+	Nonsense_Mutation	SNP	C	C	T			AC-V16-Tumor-SM-9J46H	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V16-Tumor-SM-9J46H	none	g.chr2:202150003C>T	ENST00000358485.4	+	8	1640	c.1444C>T	c.(1444-1446)Cag>Tag	p.Q482*	CASP8_ENST00000432109.2_Nonsense_Mutation_p.Q423*|CASP8_ENST00000323492.7_Nonsense_Mutation_p.Q408*|CASP8_ENST00000392259.2_3'UTR|CASP8_ENST00000264275.5_Nonsense_Mutation_p.Q440*|CASP8_ENST00000392266.3_3'UTR|CASP8_ENST00000264274.9_Nonsense_Mutation_p.Q339*	NM_001080125.1	NP_001073594.1	Q14790	CASP8_HUMAN	caspase 8, apoptosis-related cysteine peptidase	423.0					activation of caspase activity|activation of pro-apoptotic gene products|cellular component disassembly involved in apoptosis|cellular response to mechanical stimulus|induction of apoptosis by extracellular signals|induction of apoptosis by intracellular signals|positive regulation of I-kappaB kinase/NF-kappaB cascade|proteolysis involved in cellular protein catabolic process|response to tumor necrosis factor	centrosome|cytosol|mitochondrial outer membrane	cysteine-type endopeptidase activity|protein binding			breast(5)|cervix(2)|endometrium(6)|large_intestine(11)|lung(10)|ovary(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(9)|urinary_tract(3)	52.0						CTGGTACATCCAGTCACTTTG	0.527										HNSCC(4;0.00038)																									Melanoma(82;831 1348 20716 36952 40159)											0													84.0	75.0	78.0					2																	202150003.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained			ENSG00000064012	HGNC:1509	NM_001228	Approved	uc002uxt.1	ENST00000358485.4:c.1444C>T	2.37:g.202150003C>T	ENSP00000351273:p.Gln482*		O14676|Q14791|Q14792|Q14793|Q14794|Q14795|Q14796|Q15780|Q15806|Q53TT5|Q8TDI1|Q8TDI2|Q8TDI3|Q8TDI4|Q8TDI5|Q96T22|Q9C0K4|Q9UQ81	ENST00000358485.4	37	CCDS42798.1	.	.	.	.	.	.	.	.	.	.	C	37	6.188550	0.97362	.	.	ENSG00000064012	ENST00000392263;ENST00000264274;ENST00000432109;ENST00000264275;ENST00000358485;ENST00000323492;ENST00000444430	.	.	.	5.64	5.64	0.86602	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	18.6871	0.91568	0.0:1.0:0.0:0.0	.	.	.	.	X	408;339;423;440;482;408;202	.	ENSP00000264274:Q339X	Q	+	1	0	CASP8	201858248	1.000000	0.71417	1.000000	0.80357	0.931000	0.56810	5.878000	0.69682	2.655000	0.90218	0.561000	0.74099	CAG	CASP8-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000256278.3	101.645376	KEEP		+	102.216972	0.418367	41	57					42.33	20	24	33	35	0.545455	0.0	0.0	1	0	0	31.01	0.454545	1	2.26627e-22	3.41784e-22	0.09836	0	47	7946	245	80	6	10	0	0	0.0002103291	0.003	1	-9.41599	0.999244	1	1	1	1	0	98	8.0
EGFR	1956	broad.mit.edu	37	7	55220355	55220355	+	Missense_Mutation	SNP	C	C	G			AC-V16-Tumor-SM-9J46H	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V16-Tumor-SM-9J46H	none	g.chr7:55220355C>G	ENST00000275493.2	+	6	922	c.745C>G	c.(745-747)Ctg>Gtg	p.L249V	EGFR_ENST00000420316.2_Missense_Mutation_p.L249V|EGFR_ENST00000344576.2_Missense_Mutation_p.L249V|EGFR_ENST00000454757.2_Missense_Mutation_p.L196V|EGFR_ENST00000455089.1_Missense_Mutation_p.L204V|EGFR_ENST00000342916.3_Missense_Mutation_p.L249V|EGFR_ENST00000442591.1_Missense_Mutation_p.L249V	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	249.0					activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110.0	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GAGCGACTGCCTGGTAAGATG	0.672		8.0	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC			Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)																										yes	Dom	yes	Familial lung cancer	7.0	7p12.3-p12.1	1956.0	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""		"""E, O"""	0													33.0	38.0	36.0					7																	55220355.0		2203.0	4298.0	6501.0	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	ENST00000275493.2:c.745C>G	7.37:g.55220355C>G	ENSP00000275493:p.Leu249Val		O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	C	17.30	3.355898	0.61293	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000395504;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000454757;ENST00000533450	T;T;T;T;T;T;T	0.65549	-0.16;-0.16;-0.16;-0.16;-0.16;-0.16;-0.16	5.15	3.03	0.35002	Growth factor, receptor (1);Furin-like cysteine-rich domain (1);	0.077581	0.53938	D	0.000057	T	0.66655	0.2811	L	0.43701	1.375	0.52501	D	0.999958	D;P;D;D;P	0.76494	0.975;0.921;0.966;0.999;0.739	P;P;P;D;B	0.66979	0.876;0.717;0.865;0.948;0.425	T	0.66948	-0.5794	10	0.72032	D	0.01	.	7.1234	0.25458	0.0:0.6635:0.0:0.3365	.	204;249;249;249;249	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	V	204;249;119;249;249;249;249;196;43	ENSP00000415559:L204V;ENSP00000342376:L249V;ENSP00000345973:L249V;ENSP00000413843:L249V;ENSP00000275493:L249V;ENSP00000410031:L249V;ENSP00000395243:L196V	ENSP00000275493:L249V	L	+	1	2	EGFR	55187849	0.999000	0.42202	1.000000	0.80357	0.800000	0.45204	1.748000	0.38308	1.124000	0.41980	0.655000	0.94253	CTG	EGFR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000251456.2	18.862404	KEEP		+	30.387778	0.151515	15	84					42.33	10	5	44	42	0.333333	0.0	0.0	1	0	0	31.01	0.666667	0	0.0	0.0	0.11911	0	220	7893	205	15	0	0	0	0	4.798042e-05	0.003	1	-20.0	0.9999998	1	1	1	1	0	99	0.0
ARID2	196528	broad.mit.edu	37	12	46245660	46245660	+	Nonsense_Mutation	SNP	G	G	T			AC-V17-Tumor-SM-9J46I	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V17-Tumor-SM-9J46I	none	g.chr12:46245660G>T	ENST00000334344.6	+	15	3926	c.3754G>T	c.(3754-3756)Gaa>Taa	p.E1252*	ARID2_ENST00000422737.1_Nonsense_Mutation_p.E1103*|ARID2_ENST00000479608.1_3'UTR|ARID2_ENST00000444670.1_Nonsense_Mutation_p.E862*	NM_152641.2	NP_689854.2	Q68CP9	ARID2_HUMAN	AT rich interactive domain 2 (ARID, RFX-like)	1252.0					chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|protein binding|zinc ion binding			NS(1)|autonomic_ganglia(1)|breast(7)|central_nervous_system(3)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(21)|liver(20)|lung(34)|ovary(7)|pancreas(1)|prostate(2)|skin(5)|stomach(1)|upper_aerodigestive_tract(2)	116.0	Lung SC(27;0.192)|Renal(347;0.236)	Lung NSC(34;0.106)|all_lung(34;0.22)	OV - Ovarian serous cystadenocarcinoma(5;0.00691)	GBM - Glioblastoma multiforme(48;0.0153)		GGAAGCAAAGGAAGCAACAGG	0.458			"""N, S, F"""		hepatocellular carcinoma																																Rec	yes		12.0	12q12	196528.0	AT rich interactive domain 2		E	0													75.0	69.0	71.0					12																	46245660.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained			ENSG00000189079	HGNC:18037	XM_350875	Approved	uc001ros.1	ENST00000334344.6:c.3754G>T	12.37:g.46245660G>T	ENSP00000335044:p.Glu1252*		Q15KG9|Q5EB51|Q645I3|Q6ZRY5|Q7Z3I5|Q86T28|Q96SJ6|Q9HCL5	ENST00000334344.6	37	CCDS31783.1	.	.	.	.	.	.	.	.	.	.	G	44	10.730770	0.99458	.	.	ENSG00000189079	ENST00000334344;ENST00000549153;ENST00000338636;ENST00000422737;ENST00000444670	.	.	.	6.17	6.17	0.99709	.	0.042260	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.62326	D	0.03	-16.5246	20.8794	0.99867	0.0:0.0:1.0:0.0	.	.	.	.	X	1252;369;369;1103;862	.	ENSP00000335044:E1252X	E	+	1	0	ARID2	44531927	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	9.188000	0.94921	2.941000	0.99782	0.655000	0.94253	GAA	ARID2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000318380.2	6.203661	KEEP		+	23.206865	0.113043	13	102					44.53	5	9	53	72	0.357143	4.36969e-10	4.69948e-10	1	1	0	30.33	0.642857	0	0.0	0.0	0.105934	0	48	7992	245	48	0	0	0	0	6.207013e-05	0.003	1	-19.73566	0.9999734	1	1	1	1	0	115	0.0
KMT2D	8085	broad.mit.edu	37	12	49448472	49448472	+	Missense_Mutation	SNP	C	C	T			AC-V18-Tumor-SM-9J46J	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V18-Tumor-SM-9J46J	none	g.chr12:49448472C>T	ENST00000301067.7	-	3	238	c.239G>A	c.(238-240)cGg>cAg	p.R80Q		NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D																		CCGTAGCTCCCGCTGCCCGTG	0.657																																														0													25.0	30.0	29.0					12																	49448472.0		1999.0	4144.0	6143.0	SO:0001583	missense			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.239G>A	12.37:g.49448472C>T	ENSP00000301067:p.Arg80Gln			ENST00000301067.7	37	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	C	20.5	4.005820	0.74932	.	.	ENSG00000167548	ENST00000301067;ENST00000547610	T	0.80738	-1.41	5.18	5.18	0.71444	.	.	.	.	.	T	0.82208	0.4987	N	0.19112	0.55	0.35777	D	0.821372	D	0.89917	1.0	D	0.63957	0.92	D	0.87759	0.2597	9	0.87932	D	0	.	17.4702	0.87643	0.0:1.0:0.0:0.0	.	80	O14686	MLL2_HUMAN	Q	80	ENSP00000301067:R80Q	ENSP00000301067:R80Q	R	-	2	0	MLL2	47734739	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	5.431000	0.66507	2.389000	0.81357	0.557000	0.71058	CGG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	13.705012	KEEP		-	16.453913	0.225	9	31					74.84	6	4	19	20	0.4	0.0	0.0	1	0	0	31.87	0.6	1	0.000442599	0.000485791	0.335167	0	198	7847	271	17	0	0	0	0	6.699097e-05	0.003	1	-18.87253	0.9999988	1	1	1	1	0	40	0.0
TP53	7157	broad.mit.edu	37	17	7578392	7578392	+	Missense_Mutation	SNP	C	C	T			AC-V18-Tumor-SM-9J46J	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V18-Tumor-SM-9J46J	none	g.chr17:7578392C>T	ENST00000420246.2	-	5	670	c.538G>A	c.(538-540)Gag>Aag	p.E180K	TP53_ENST00000445888.2_Missense_Mutation_p.E180K|TP53_ENST00000359597.4_Missense_Mutation_p.E180K|TP53_ENST00000455263.2_Missense_Mutation_p.E180K|TP53_ENST00000574684.1_5'UTR|TP53_ENST00000413465.2_Missense_Mutation_p.E180K|TP53_ENST00000269305.4_Missense_Mutation_p.E180K	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	180.0	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.		E -> A (in a sporadic cancer; somatic mutation).|E -> D (in sporadic cancers; somatic mutation).|E -> G (in a sporadic cancer; somatic mutation).|E -> K (in LFS; germline mutation and in sporadic cancers; somatic mutation).|E -> Q (in sporadic cancers; somatic mutation).|E -> V (in a sporadic cancer; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.E180*(14)|p.P177_C182delPHHERC(8)|p.0?(8)|p.E180K(5)|p.C176_R181delCPHHER(3)|p.R174fs*24(3)|p.H178_S183delHHERCS(3)|p.R175_E180delRCPHHE(3)|p.P177fs*3(2)|p.V173fs*59(2)|p.C176fs*65(1)|p.V173fs*23(1)|p.V172_E180delVVRRCPHHE(1)|p.E180Q(1)|p.R81fs*24(1)|p.E180>DGRCPHQ(1)|p.R174_E180>K(1)|p.H46_S51delHHERCS(1)|p.H178fs*6(1)|p.P177_E180delPHHE(1)|p.R42fs*24(1)|p.H85_S90delHHERCS(1)|p.R174fs*3(1)|p.E180fs*6(1)|p.E171fs*61(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185.0		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GAGCAGCGCTCATGGTGGGGG	0.637		111.0	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)																									Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17.0	17p13	7157.0	tumor protein p53		"""L, E, M, O"""	66	Deletion - In frame(21)|Substitution - Nonsense(14)|Deletion - Frameshift(14)|Whole gene deletion(8)|Substitution - Missense(6)|Insertion - Frameshift(1)|Complex - insertion inframe(1)|Complex - deletion inframe(1)	large_intestine(16)|upper_aerodigestive_tract(9)|urinary_tract(6)|breast(6)|lung(5)|oesophagus(4)|bone(4)|central_nervous_system(3)|haematopoietic_and_lymphoid_tissue(3)|ovary(3)|stomach(2)|liver(2)|pancreas(2)|prostate(1)	GRCh37	CM941328	TP53	M							47.0	47.0	47.0					17																	7578392.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	ENST00000420246.2:c.538G>A	17.37:g.7578392C>T	ENSP00000391127:p.Glu180Lys		Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	26.1	4.704841	0.88924	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99784	-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74	5.47	5.47	0.80525	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99588	0.9851	L	0.48935	1.535	0.58432	D	0.999997	D;D;B;D;D;D;D	0.89917	0.985;0.999;0.303;0.997;0.999;1.0;1.0	P;D;B;D;D;D;D	0.87578	0.869;0.986;0.203;0.915;0.992;0.995;0.998	D	0.97925	1.0317	10	0.72032	D	0.01	-40.5855	17.1938	0.86887	0.0:1.0:0.0:0.0	.	141;180;180;87;180;180;180	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	K	180;180;180;180;180;180;169;87;48;87;48	ENSP00000410739:E180K;ENSP00000352610:E180K;ENSP00000269305:E180K;ENSP00000398846:E180K;ENSP00000391127:E180K;ENSP00000391478:E180K;ENSP00000425104:E48K;ENSP00000423862:E87K	ENSP00000269305:E180K	E	-	1	0	TP53	7519117	1.000000	0.71417	0.986000	0.45419	0.845000	0.48019	4.918000	0.63376	2.735000	0.93741	0.563000	0.77884	GAG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000367401.1	46.27221	KEEP		-	47.99332	0.769231	20	6					74.84	10	13	4	3	0.565217	0.0	0.0	1	0	0	31.87	0.434783	1	5.26018e-13	7.59108e-13	0.608945	0	52	7955	275	49	0	2	0	0	0.0001348399	0.003	1	-13.37813	0.9999957	1	1	1	1	0	26	4.0
KMT2A	4297	broad.mit.edu	37	11	118375490	118375490	+	Missense_Mutation	SNP	G	G	C			AC-V18-Tumor-SM-9J46K	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V18-Tumor-SM-9J46K	none	g.chr11:118375490G>C	ENST00000534358.1	+	27	8906	c.8883G>C	c.(8881-8883)aaG>aaC	p.K2961N	KMT2A_ENST00000354520.4_Missense_Mutation_p.K2920N|KMT2A_ENST00000389506.5_Missense_Mutation_p.K2958N	NM_001197104.1|NM_005933.3	NP_001184033.1|NP_005924.2			lysine (K)-specific methyltransferase 2A																		CAGGGGAGAAGAGAGTAACCA	0.522																																														0													61.0	63.0	62.0					11																	118375490.0		2200.0	4295.0	6495.0	SO:0001583	missense			ENSG00000118058	HGNC:7132	NM_005933	Approved		ENST00000534358.1:c.8883G>C	11.37:g.118375490G>C	ENSP00000436786:p.Lys2961Asn			ENST00000534358.1	37	CCDS55791.1	.	.	.	.	.	.	.	.	.	.	G	12.21	1.869859	0.33069	.	.	ENSG00000118058	ENST00000534358;ENST00000389506;ENST00000354520;ENST00000359313	D;D;D	0.83992	-1.79;-1.79;-1.76	6.17	5.24	0.73138	.	0.168771	0.53938	D	0.000047	T	0.71719	0.3373	L	0.36672	1.1	0.47778	D	0.999514	P;P	0.43094	0.799;0.799	B;B	0.35859	0.212;0.212	T	0.73658	-0.3913	10	0.66056	D	0.02	.	7.3119	0.26479	0.168:0.1401:0.6919:0.0	.	2961;2958	E9PQG7;Q03164	.;MLL1_HUMAN	N	2961;2958;2920;1868	ENSP00000436786:K2961N;ENSP00000374157:K2958N;ENSP00000346516:K2920N	ENSP00000346516:K2920N	K	+	3	2	MLL	117880700	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	3.903000	0.56318	1.565000	0.49641	0.655000	0.94253	AAG	KMT2A-001	NOVEL	basic|appris_candidate_longest|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000389228.2	6.370526	KEEP		+	15.157319	0.125	8	56					44.29	5	6	30	35	0.454545	0.0	0.0	1	0	0	32.77	0.545455	0	0.0	0.0	0.361761	0	47	7984	261	39	0	2	0	0	7.882397e-05	0.003	1	-3.654186	0.9999386	1	1	1	1	0	64	0.0
KMT2D	8085	broad.mit.edu	37	12	49448472	49448472	+	Missense_Mutation	SNP	C	C	T			AC-V18-Tumor-SM-9J46K	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V18-Tumor-SM-9J46K	none	g.chr12:49448472C>T	ENST00000301067.7	-	3	238	c.239G>A	c.(238-240)cGg>cAg	p.R80Q		NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D																		CCGTAGCTCCCGCTGCCCGTG	0.657																																														0													25.0	30.0	29.0					12																	49448472.0		1999.0	4144.0	6143.0	SO:0001583	missense			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.239G>A	12.37:g.49448472C>T	ENSP00000301067:p.Arg80Gln			ENST00000301067.7	37	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	C	20.5	4.005820	0.74932	.	.	ENSG00000167548	ENST00000301067;ENST00000547610	T	0.80738	-1.41	5.18	5.18	0.71444	.	.	.	.	.	T	0.82208	0.4987	N	0.19112	0.55	0.35777	D	0.821372	D	0.89917	1.0	D	0.63957	0.92	D	0.87759	0.2597	9	0.87932	D	0	.	17.4702	0.87643	0.0:1.0:0.0:0.0	.	80	O14686	MLL2_HUMAN	Q	80	ENSP00000301067:R80Q	ENSP00000301067:R80Q	R	-	2	0	MLL2	47734739	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	5.431000	0.66507	2.389000	0.81357	0.557000	0.71058	CGG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	33.149997	KEEP		-	33.535872	0.388889	14	22					44.29	8	9	17	15	0.529412	0.0	0.0	1	0	0	32.77	0.470588	1	4.7546e-09	6.06736e-09	0.500413	0	198	7847	271	17	0	0	0	0	7.732543e-05	0.003	1	-20.0	0.9999996	1	1	1	1	0	36	0.0
TP53	7157	broad.mit.edu	37	17	7578392	7578392	+	Missense_Mutation	SNP	C	C	T			AC-V18-Tumor-SM-9J46K	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V18-Tumor-SM-9J46K	none	g.chr17:7578392C>T	ENST00000420246.2	-	5	670	c.538G>A	c.(538-540)Gag>Aag	p.E180K	TP53_ENST00000574684.1_5'UTR|TP53_ENST00000455263.2_Missense_Mutation_p.E180K|TP53_ENST00000413465.2_Missense_Mutation_p.E180K|TP53_ENST00000445888.2_Missense_Mutation_p.E180K|TP53_ENST00000269305.4_Missense_Mutation_p.E180K|TP53_ENST00000359597.4_Missense_Mutation_p.E180K	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	180.0	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.		E -> A (in a sporadic cancer; somatic mutation).|E -> D (in sporadic cancers; somatic mutation).|E -> G (in a sporadic cancer; somatic mutation).|E -> K (in LFS; germline mutation and in sporadic cancers; somatic mutation).|E -> Q (in sporadic cancers; somatic mutation).|E -> V (in a sporadic cancer; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.E180*(14)|p.P177_C182delPHHERC(8)|p.0?(8)|p.E180K(5)|p.C176_R181delCPHHER(3)|p.R174fs*24(3)|p.H178_S183delHHERCS(3)|p.R175_E180delRCPHHE(3)|p.P177fs*3(2)|p.V173fs*59(2)|p.C176fs*65(1)|p.V173fs*23(1)|p.V172_E180delVVRRCPHHE(1)|p.E180Q(1)|p.R81fs*24(1)|p.E180>DGRCPHQ(1)|p.R174_E180>K(1)|p.H46_S51delHHERCS(1)|p.H178fs*6(1)|p.P177_E180delPHHE(1)|p.R42fs*24(1)|p.H85_S90delHHERCS(1)|p.R174fs*3(1)|p.E180fs*6(1)|p.E171fs*61(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185.0		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GAGCAGCGCTCATGGTGGGGG	0.637		111.0	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)																									Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17.0	17p13	7157.0	tumor protein p53		"""L, E, M, O"""	66	Deletion - In frame(21)|Substitution - Nonsense(14)|Deletion - Frameshift(14)|Whole gene deletion(8)|Substitution - Missense(6)|Insertion - Frameshift(1)|Complex - insertion inframe(1)|Complex - deletion inframe(1)	large_intestine(16)|upper_aerodigestive_tract(9)|urinary_tract(6)|breast(6)|lung(5)|oesophagus(4)|bone(4)|central_nervous_system(3)|haematopoietic_and_lymphoid_tissue(3)|ovary(3)|stomach(2)|liver(2)|pancreas(2)|prostate(1)	GRCh37	CM941328	TP53	M							47.0	47.0	47.0					17																	7578392.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	ENST00000420246.2:c.538G>A	17.37:g.7578392C>T	ENSP00000391127:p.Glu180Lys		Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	26.1	4.704841	0.88924	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99784	-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74	5.47	5.47	0.80525	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99588	0.9851	L	0.48935	1.535	0.58432	D	0.999997	D;D;B;D;D;D;D	0.89917	0.985;0.999;0.303;0.997;0.999;1.0;1.0	P;D;B;D;D;D;D	0.87578	0.869;0.986;0.203;0.915;0.992;0.995;0.998	D	0.97925	1.0317	10	0.72032	D	0.01	-40.5855	17.1938	0.86887	0.0:1.0:0.0:0.0	.	141;180;180;87;180;180;180	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	K	180;180;180;180;180;180;169;87;48;87;48	ENSP00000410739:E180K;ENSP00000352610:E180K;ENSP00000269305:E180K;ENSP00000398846:E180K;ENSP00000391127:E180K;ENSP00000391478:E180K;ENSP00000425104:E48K;ENSP00000423862:E87K	ENSP00000269305:E180K	E	-	1	0	TP53	7519117	1.000000	0.71417	0.986000	0.45419	0.845000	0.48019	4.918000	0.63376	2.735000	0.93741	0.563000	0.77884	GAG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000367401.1	77.06661	KEEP		-	80.630694	0.828571	29	6					44.29	17	20	3	4	0.540541	0.0	0.0	1	0	0	32.77	0.459459	1	9.04072e-19	1.39088e-18	0.779181	0	52	7955	275	49	0	2	0	0	0.0001409408	0.003	1	-18.82917	0.9999962	1	1	1	1	0	35	4.0
KMT2D	8085	broad.mit.edu	37	12	49431021	49431021	+	Nonsense_Mutation	SNP	G	G	C			AC-V23-Tumor-SM-9J46P	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V23-Tumor-SM-9J46P	none	g.chr12:49431021G>C	ENST00000301067.7	-	34	10117	c.10118C>G	c.(10117-10119)tCa>tGa	p.S3373*	KMT2D_ENST00000549743.1_5'UTR	NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D																		CACTGGCTGTGAGCTCTGCTG	0.577																																														0													42.0	43.0	43.0					12																	49431021.0		2134.0	4258.0	6392.0	SO:0001587	stop_gained			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.10118C>G	12.37:g.49431021G>C	ENSP00000301067:p.Ser3373*			ENST00000301067.7	37	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	G	50	17.149767	0.99880	.	.	ENSG00000167548	ENST00000301067	.	.	.	5.47	4.56	0.56223	.	0.672540	0.12379	N	0.474055	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	13.0862	0.59142	0.0:0.0:0.7091:0.2909	.	.	.	.	X	3373	.	ENSP00000301067:S3373X	S	-	2	0	MLL2	47717288	0.990000	0.36364	0.678000	0.29963	0.883000	0.51084	2.497000	0.45354	1.427000	0.47276	0.561000	0.74099	TCA	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	8.996858	KEEP		-	9.572322	0.285714	4	10					39.64	0	4	7	7	0.0	0.0	0.0	1	0	0	34.95	1.0	0	0.0	0.0	1.0	0	165	7965	180	22	0	0	0	0	4.938559e-05	0.003	1	-11.71328	1.0	1	1	1	1	0	14	0.0
PTEN	5728	broad.mit.edu	37	10	89720659	89720659	+	Missense_Mutation	SNP	G	G	T			AC-V25-Tumor-SM-9J46R	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V25-Tumor-SM-9J46R	none	g.chr10:89720659G>T	ENST00000371953.3	+	8	2167	c.810G>T	c.(808-810)atG>atT	p.M270I	PTEN_ENST00000472832.1_3'UTR	NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	270.0	C2 tensin-type.				activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.R55fs*1(5)|p.?(3)|p.N212fs*1(2)|p.Y27fs*1(2)|p.G165_*404del(1)|p.M270I(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771.0		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		AGGACAAAATGTTTCACTTTT	0.264		31.0	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""			Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)																										yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10.0	10q23.3	5728.0	phosphatase and tensin homolog gene		"""L, E, M, O"""	51	Whole gene deletion(37)|Deletion - Frameshift(9)|Unknown(3)|Substitution - Missense(1)|Deletion - In frame(1)	prostate(16)|central_nervous_system(11)|skin(6)|lung(4)|haematopoietic_and_lymphoid_tissue(3)|breast(3)|ovary(3)|endometrium(2)|urinary_tract(2)|soft_tissue(1)											24.0	25.0	25.0					10																	89720659.0		2177.0	4258.0	6435.0	SO:0001583	missense	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	ENST00000371953.3:c.810G>T	10.37:g.89720659G>T	ENSP00000361021:p.Met270Ile		B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	G	18.65	3.669507	0.67814	.	.	ENSG00000171862	ENST00000371953	D	0.84223	-1.82	5.13	5.13	0.70059	Tensin phosphatase, C2 domain (2);C2 calcium/lipid-binding domain, CaLB (1);	0.000000	0.85682	D	0.000000	D	0.82861	0.5129	L	0.41236	1.265	0.80722	D	1	P	0.44195	0.828	B	0.43950	0.437	T	0.81835	-0.0750	9	.	.	.	-9.894	18.5632	0.91108	0.0:0.0:1.0:0.0	.	270	P60484	PTEN_HUMAN	I	270	ENSP00000361021:M270I	.	M	+	3	0	PTEN	89710639	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	9.429000	0.97481	2.399000	0.81585	0.591000	0.81541	ATG	PTEN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000049241.1	6.060773	KEEP		+	7.195867	0.28	7	18					56.73	9	0	23	5	1.0	1.0	1.0	1	1	0	29.94	0.0	0	0.0	0.0	0.047766	0	158	7319	667	132	51	7	0	0	0.0006179062	0.003	1	-3.957507	0.9156636	0	1	1	1	0	25	2.0
TP63	8626	broad.mit.edu	37	3	189526299	189526299	+	Missense_Mutation	SNP	A	A	C			AC-V26-Tumor-SM-9J46S	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V26-Tumor-SM-9J46S	none	g.chr3:189526299A>C	ENST00000264731.3	+	4	652	c.563A>C	c.(562-564)aAg>aCg	p.K188T	TP63_ENST00000382063.4_Intron|TP63_ENST00000437221.1_Missense_Mutation_p.K94T|TP63_ENST00000418709.2_Missense_Mutation_p.K188T|TP63_ENST00000392463.2_Missense_Mutation_p.K94T|TP63_ENST00000392460.3_Missense_Mutation_p.K188T|TP63_ENST00000449992.1_Intron|TP63_ENST00000320472.5_Missense_Mutation_p.K188T|TP63_ENST00000440651.2_Missense_Mutation_p.K188T|TP63_ENST00000392461.3_Missense_Mutation_p.K94T|TP63_ENST00000456148.1_Missense_Mutation_p.K94T|TP63_ENST00000354600.5_Missense_Mutation_p.K94T	NM_001114978.1|NM_003722.4	NP_001108450.1|NP_003713.3	Q9H3D4	P63_HUMAN	tumor protein p63	188.0					anti-apoptosis|cellular response to UV|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|mitotic cell cycle G1/S transition DNA damage checkpoint|negative regulation of transcription from RNA polymerase II promoter|Notch signaling pathway|positive regulation of Notch signaling pathway|protein homotetramerization|regulation of neuron apoptosis|response to gamma radiation|response to X-ray	chromatin|cytosol|dendrite|Golgi apparatus|transcription factor complex	chromatin binding|damaged DNA binding|double-stranded DNA binding|identical protein binding|metal ion binding|p53 binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity			breast(2)|central_nervous_system(2)|cervix(1)|endometrium(7)|kidney(5)|large_intestine(12)|lung(15)|ovary(2)|skin(9)|upper_aerodigestive_tract(6)	61.0	all_cancers(143;3.35e-10)|Ovarian(172;0.0925)		Lung(62;3.33e-05)	GBM - Glioblastoma multiforme(93;0.0227)		AGCACCGCCAAGTCGGCCACC	0.627										HNSCC(45;0.13)																																				0													99.0	83.0	89.0					3																	189526299.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000073282	HGNC:15979	NM_003722	Approved	uc003fry.2	ENST00000264731.3:c.563A>C	3.37:g.189526299A>C	ENSP00000264731:p.Lys188Thr		O75080|O75195|O75922|O76078|Q6VEG2|Q6VEG3|Q6VEG4|Q6VFJ1|Q6VFJ2|Q6VFJ3|Q6VH20|Q7LDI3|Q7LDI4|Q7LDI5|Q96KR0|Q9H3D2|Q9H3D3|Q9H3P8|Q9NPH7|Q9P1B4|Q9P1B5|Q9P1B6|Q9P1B7|Q9UBV9|Q9UE10|Q9UP26|Q9UP27|Q9UP28|Q9UP74	ENST00000264731.3	37	CCDS3293.1	.	.	.	.	.	.	.	.	.	.	A	26.5	4.739089	0.89573	.	.	ENSG00000073282	ENST00000264731;ENST00000418709;ENST00000320472;ENST00000392460;ENST00000440651;ENST00000354600;ENST00000434928;ENST00000437221;ENST00000392463;ENST00000392461;ENST00000456148	D;D;D;D;D;D;D;D;D;D;D	0.99859	-7.23;-7.23;-7.23;-7.23;-7.23;-7.23;-7.23;-7.23;-7.23;-7.23;-7.23	5.71	5.71	0.89125	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99873	0.9940	M	0.90019	3.08	0.80722	D	1	D;D;D;D;D;D;D;D;D	0.89917	1.0;1.0;0.999;1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D;D;D	0.97110	1.0;1.0;0.997;1.0;1.0;1.0;1.0;1.0;1.0	D	0.96409	0.9303	9	.	.	.	-4.6965	15.1602	0.72778	1.0:0.0:0.0:0.0	.	188;188;94;94;94;94;188;188;188	Q9H3D4-7;Q9H3D4-11;Q9H3D4-4;Q9H3D4-2;Q9H3D4-6;C9D7C9;Q9H3D4-3;Q9H3D4;Q9H3D4-5	.;.;.;.;.;.;.;P63_HUMAN;.	T	188;188;188;188;188;94;94;94;94;94;94	ENSP00000264731:K188T;ENSP00000407144:K188T;ENSP00000317510:K188T;ENSP00000376253:K188T;ENSP00000394337:K188T;ENSP00000346614:K94T;ENSP00000401661:K94T;ENSP00000392488:K94T;ENSP00000376256:K94T;ENSP00000376254:K94T;ENSP00000389485:K94T	.	K	+	2	0	TP63	191008993	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	9.339000	0.96797	2.182000	0.69389	0.460000	0.39030	AAG	TP63-001	KNOWN	basic|CCDS	protein_coding		protein_coding	OTTHUMT00000343865.1	133.135986	KEEP		+	135.392046	0.670455	59	29					43.42	40	35	16	18	0.466667	0.0	0.0	1	0	0	31.43		0	0.0	0.0	0.870114	0	49	8185	88	11	0	0	0	0	3.34221e-05	0.003	1	-20.0	1.0	1	1	1	1	0	88	0.0
PIK3CA	5290	broad.mit.edu	37	3	178936082	178936082	+	Missense_Mutation	SNP	G	G	A	rs121913273		AC-V28-Tumor-SM-9J46U	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V28-Tumor-SM-9J46U	none	g.chr3:178936082G>A	ENST00000263967.3	+	10	1781	c.1624G>A	c.(1624-1626)Gaa>Aaa	p.E542K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	542.0	PI3K helical.		E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation).|E -> Q (in cancer).|E -> V (in cancer).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E542K(545)|p.E542Q(10)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269.0	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TCCTCTCTCTGAAATCACTGA	0.333	E542K(BT483_BREAST)|E542K(CAL51_BREAST)|E542K(HGC27_STOMACH)|E542K(IM95_STOMACH)|E542K(JHUEM1_ENDOMETRIUM)|E542K(NCIH1341_LUNG)|E542K(SW948_LARGE_INTESTINE)|E542K(T84_LARGE_INTESTINE)|E542K(VMCUB1_URINARY_TRACT)	57.0	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																									Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3.0	3q26.3	5290.0	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	555	Substitution - Missense(555)	breast(176)|large_intestine(166)|urinary_tract(45)|endometrium(37)|skin(19)|lung(18)|stomach(16)|ovary(16)|thyroid(14)|upper_aerodigestive_tract(9)|central_nervous_system(7)|cervix(6)|liver(6)|oesophagus(5)|penis(4)|kidney(3)|soft_tissue(2)|haematopoietic_and_lymphoid_tissue(2)|prostate(2)|biliary_tract(1)|pituitary(1)											56.0	56.0	56.0					3																	178936082.0		1809.0	4069.0	5878.0	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	ENST00000263967.3:c.1624G>A	3.37:g.178936082G>A	ENSP00000263967:p.Glu542Lys		Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	34	5.360420	0.95877	.	.	ENSG00000121879	ENST00000263967	T	0.62105	0.05	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.69287	0.3094	L	0.41356	1.27	0.80722	D	1	D	0.65815	0.995	D	0.63192	0.912	T	0.60296	-0.7291	10	0.09843	T	0.71	-23.9623	20.0024	0.97423	0.0:0.0:1.0:0.0	.	542	P42336	PK3CA_HUMAN	K	542	ENSP00000263967:E542K	ENSP00000263967:E542K	E	+	1	0	PIK3CA	180418776	1.000000	0.71417	1.000000	0.80357	0.978000	0.69477	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAA	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000348409.2	215.782283	KEEP		+	231.346912	0.278409	98	254					47.31	62	69	133	204	0.473282	0.0	0.0	1	0	0	29.84	0.526718	1	2.09629e-50	4.22195e-50	0.048971	0	107	7922	236	53	8	7	0	0	0.0001815703	0.003	1	-6.823809	0.999584	1	1	1	1	0	352	280.0
PIK3CB	5291	broad.mit.edu	37	3	138417865	138417865	+	Nonsense_Mutation	SNP	C	C	A			AC-V28-Tumor-SM-9J46U	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V28-Tumor-SM-9J46U	none	g.chr3:138417865C>A	ENST00000477593.1	-	12	1727	c.1654G>T	c.(1654-1656)Gaa>Taa	p.E552*	PIK3CB_ENST00000289153.2_Nonsense_Mutation_p.E552*|PIK3CB_ENST00000544716.1_5'UTR			P42338	PK3CB_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	552.0	PI3K helical.				activation of MAPK activity|chemotaxis|fibroblast growth factor receptor signaling pathway|G-protein coupled receptor protein signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell receptor signaling pathway	phosphatidylinositol 3-kinase complex	1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E552K(1)		NS(1)|breast(3)|endometrium(5)|kidney(2)|large_intestine(4)|lung(17)|ovary(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(4)	41.0						ATTTCATTTTCACACAGTTGA	0.373																																														1	Substitution - Missense(1)	endometrium(1)											98.0	98.0	98.0					3																	138417865.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained			ENSG00000051382	HGNC:8976		Approved	uc011bmq.3	ENST00000477593.1:c.1654G>T	3.37:g.138417865C>A	ENSP00000418143:p.Glu552*		D3DNF0|Q24JU2	ENST00000477593.1	37	CCDS3104.1	.	.	.	.	.	.	.	.	.	.	C	31	5.059621	0.93846	.	.	ENSG00000051382	ENST00000477593;ENST00000289153	.	.	.	5.91	5.01	0.66863	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.30078	T	0.28	-17.9641	16.5318	0.84362	0.1311:0.8689:0.0:0.0	.	.	.	.	X	552	.	ENSP00000289153:E552X	E	-	1	0	PIK3CB	139900555	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	5.758000	0.68776	2.805000	0.96524	0.460000	0.39030	GAA	PIK3CB-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000358019.1	34.337805	KEEP		-	58.847542	0.144279	29	172					47.31	24	15	100	123	0.384615	3.93418e-24	4.15074e-24	1	1	0	29.84	0.615385	0	0.0	0.0	0.069456	0	49	8053	156	48	28	0	0	0	0.0002467579	0.003	1	-14.60176	0.9995807	1	1	1	1	0	201	0.0
EP300	2033	broad.mit.edu	37	22	41568501	41568501	+	Splice_Site	SNP	A	A	G			AC-V28-Tumor-SM-9J46U	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V28-Tumor-SM-9J46U	none	g.chr22:41568501A>G	ENST00000263253.7	+	28	5671		c.e28-1		RP1-85F18.6_ENST00000415054.1_RNA	NM_001429.3	NP_001420.2	Q09472	EP300_HUMAN	E1A binding protein p300						apoptosis|cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|histone H4 acetylation|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|response to estrogen stimulus|response to hypoxia	centrosome|histone acetyltransferase complex	androgen receptor binding|beta-catenin binding|DNA binding|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|transcription coactivator activity|zinc ion binding			NS(2)|breast(11)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(31)|kidney(5)|large_intestine(31)|liver(2)|lung(33)|ovary(2)|pancreas(4)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(16)	171.0						ATGTTTTCACAGGATATTTTT	0.328			"""T,  N, F, Mis, O"""	"""MLL, RUNXBP2"""	"""colorectal, breast, pancreatic, AML, ALL, DLBCL"""				Rubinstein-Taybi syndrome																												Rec	yes		22.0	22q13	2033.0	300 kd E1A-Binding protein gene		"""L, E"""	0													57.0	55.0	55.0					22																	41568501.0		2203.0	4300.0	6503.0	SO:0001630	splice_region_variant	Familial Cancer Database	Broad Thumb-Hallux syndrome	ENSG00000100393	HGNC:3373	NM_001429	Approved	uc003azl.4	ENST00000263253.7:c.4453-1A>G	22.37:g.41568501A>G			B1AKC2	ENST00000263253.7	37	CCDS14010.1	.	.	.	.	.	.	.	.	.	.	A	18.28	3.590097	0.66105	.	.	ENSG00000100393	ENST00000263253	.	.	.	5.96	5.96	0.96718	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.4484	0.83959	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	EP300	39898447	1.000000	0.71417	0.983000	0.44433	0.645000	0.38454	8.697000	0.91307	2.285000	0.76669	0.533000	0.62120	.	EP300-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000320600.1	75.233654	KEEP	Intron	+	83.598188	0.254902	39	114					47.31	22	20	60	66	0.47619	0.0	0.0	1	0	0	29.84		0	0.0	0.0	0.086207	0	52	8113	144	19	6	0	0	0	8.237103e-05	0.003	1	-20.0	0.9999999	1	1	1	1	0	153	0.0
KMT2C	58508	broad.mit.edu	37	7	151962295	151962295	+	Splice_Site	SNP	C	C	T			AC-V28-Tumor-SM-9J46U	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V28-Tumor-SM-9J46U	none	g.chr7:151962295C>T	ENST00000355193.2	-	8	1231		c.e8-1		KMT2C_ENST00000262189.6_Splice_Site					lysine (K)-specific methyltransferase 2C																		TCTTCCTTCGCTATAATTAAC	0.368																																														0													65.0	61.0	62.0					7																	151962295.0		2203.0	4300.0	6503.0	SO:0001630	splice_region_variant			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.1013-1G>A	7.37:g.151962295C>T				ENST00000355193.2	37		.	.	.	.	.	.	.	.	.	.	C	9.307	1.054685	0.19907	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	.	.	.	4.65	3.77	0.43336	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.0062	0.58705	0.0:0.9211:0.0:0.0789	.	.	.	.	.	-1	.	.	.	-	.	.	MLL3	151593228	1.000000	0.71417	0.998000	0.56505	0.004000	0.04260	4.735000	0.62051	1.072000	0.40860	-0.262000	0.10625	.	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		-31.69329	KEEP	Intron	-	14.211389	0.047619	10	200					47.31	9	13	142	194	0.590909	0.0	0.0	1	0	0	29.84	0.409091	1	2.37509e-13	3.21714e-13	0.055883	0	47	8082	171	29	3	2	0	0	7.621567e-05	0.003	1	-3.608049	0.9999417	1	1	1	1	0	210	0.0
KMT2C	58508	broad.mit.edu	37	7	151859798	151859798	+	Missense_Mutation	SNP	G	G	A			AC-V29-Tumor-SM-9J46V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V29-Tumor-SM-9J46V	none	g.chr7:151859798G>A	ENST00000355193.2	-	43	11082	c.10864C>T	c.(10864-10866)Cca>Tca	p.P3622S	KMT2C_ENST00000262189.6_Missense_Mutation_p.P3622S					lysine (K)-specific methyltransferase 2C																		GGAGTTGATGGAGCCTTGGTG	0.448																																														0													91.0	83.0	85.0					7																	151859798.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.10864C>T	7.37:g.151859798G>A	ENSP00000347325:p.Pro3622Ser			ENST00000355193.2	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	17.26|17.26	3.344071|3.344071	0.61073|0.61073	.|.	.|.	ENSG00000055609|ENSG00000055609	ENST00000262189;ENST00000355193;ENST00000424877|ENST00000360104	D;D;D|.	0.93659|.	-2.08;-2.0;-3.26|.	4.99|4.99	4.99|4.99	0.66335|0.66335	.|.	0.000000|.	0.40064|.	N|.	0.001186|.	T|T	0.69548|0.69548	0.3123|0.3123	L|L	0.49350|0.49350	1.555|1.555	0.80722|0.80722	D|D	1|1	D;D;D|.	0.89917|.	1.0;1.0;1.0|.	D;D;D|.	0.91635|.	0.996;0.999;0.999|.	T|T	0.66288|0.66288	-0.5961|-0.5961	10|5	0.87932|.	D|.	0|.	.|.	18.4893|18.4893	0.90841|0.90841	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	3622;2683;3622|.	Q8NEZ4;Q8NEZ4-2;Q8NEZ4-3|.	MLL3_HUMAN;.;.|.	S|F	3622;3622;208|1127	ENSP00000262189:P3622S;ENSP00000347325:P3622S;ENSP00000410411:P208S|.	ENSP00000262189:P3622S|.	P|S	-|-	1|2	0|0	MLL3|MLL3	151490731|151490731	1.000000|1.000000	0.71417|0.71417	0.802000|0.802000	0.32245|0.32245	0.965000|0.965000	0.64279|0.64279	9.255000|9.255000	0.95524|0.95524	2.590000|2.590000	0.87494|0.87494	0.650000|0.650000	0.86243|0.86243	CCA|TCC	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		35.298115	KEEP		-	39.45859	0.26506	22	61					42.5	12	11	35	45	0.521739	0.0	0.0	1	0	0	32.34	0.478261	1	1.50039e-11	2.33336e-11	0.608945	0	46	8022	235	25	6	0	0	0	0.0001060892	0.003	1	-18.52333	0.999997	1	1	1	1	0	83	0.0
KMT2C	58508	broad.mit.edu	37	7	151859749	151859749	+	Nonsense_Mutation	SNP	G	G	C			AC-V29-Tumor-SM-9J46V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V29-Tumor-SM-9J46V	none	g.chr7:151859749G>C	ENST00000355193.2	-	43	11131	c.10913C>G	c.(10912-10914)tCa>tGa	p.S3638*	KMT2C_ENST00000262189.6_Nonsense_Mutation_p.S3638*					lysine (K)-specific methyltransferase 2C																		GGTAGTTTCTGAGATGCCTGG	0.502																																														0													104.0	99.0	101.0					7																	151859749.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.10913C>G	7.37:g.151859749G>C	ENSP00000347325:p.Ser3638*			ENST00000355193.2	37		.	.	.	.	.	.	.	.	.	.	G	53	20.076991	0.99927	.	.	ENSG00000055609	ENST00000262189;ENST00000355193;ENST00000424877	.	.	.	5.51	5.51	0.81932	.	0.365080	0.19586	N	0.110730	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.72032	D	0.01	.	19.4545	0.94882	0.0:0.0:1.0:0.0	.	.	.	.	X	3638;3638;224	.	ENSP00000262189:S3638X	S	-	2	0	MLL3	151490682	1.000000	0.71417	0.787000	0.31911	0.299000	0.27559	7.635000	0.83286	2.590000	0.87494	0.650000	0.86243	TCA	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		15.484435	KEEP		-	17.17344	0.264706	9	25					42.5	5	6	12	18	0.454545	0.0	0.0	1	0	0	32.34	0.545455	0	0.0	0.0	0.361761	0	44	8060	133	82	11	4	0	0	0.0001612338	0.003	1	-4.155251	0.9998106	1	1	1	1	0	34	0.0
PTEN	5728	broad.mit.edu	37	10	89717615	89717615	+	Nonsense_Mutation	SNP	C	C	T	rs121909227		AC-V29-Tumor-SM-9J46V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V29-Tumor-SM-9J46V	none	g.chr10:89717615C>T	ENST00000371953.3	+	7	1997	c.640C>T	c.(640-642)Cag>Tag	p.Q214*	PTEN_ENST00000472832.1_3'UTR	NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	214.0	C2 tensin-type.				activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.Q214*(10)|p.R55fs*1(5)|p.N212fs*1(2)|p.Y27fs*1(2)|p.G165_*404del(1)|p.Q214fs*1(1)|p.?(1)|p.Q214fs*22(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771.0		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		TGCAGATCCTCAGTTTGTGGT	0.388		31.0	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""			Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)																										yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10.0	10q23.3	5728.0	phosphatase and tensin homolog gene		"""L, E, M, O"""	60	Whole gene deletion(37)|Substitution - Nonsense(10)|Deletion - Frameshift(10)|Deletion - In frame(1)|Complex - frameshift(1)|Unknown(1)	prostate(16)|central_nervous_system(11)|endometrium(8)|skin(7)|lung(5)|haematopoietic_and_lymphoid_tissue(3)|breast(3)|ovary(3)|urinary_tract(2)|cervix(1)|soft_tissue(1)	GRCh37	CM981672	PTEN	M	rs121909227						112.0	99.0	103.0					10																	89717615.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	ENST00000371953.3:c.640C>T	10.37:g.89717615C>T	ENSP00000361021:p.Gln214*		B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	C	49	15.574246	0.99838	.	.	ENSG00000171862	ENST00000371953	.	.	.	5.67	5.67	0.87782	.	0.164422	0.56097	D	0.000025	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	.	.	.	-2.2072	19.7712	0.96366	0.0:1.0:0.0:0.0	.	.	.	.	X	214	.	.	Q	+	1	0	PTEN	89707595	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.452000	0.80683	2.677000	0.91161	0.585000	0.79938	CAG	PTEN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000049241.1	24.77166	KEEP		+	26.265749	0.302326	13	30					42.5	7	11	20	14	0.611111	0.0	0.0	1	0	0	32.34	0.388889	1	1.02788e-11	1.60787e-11	0.520397	0	47	7996	193	76	11	11	0	0	0.0002304612	0.003	1	-4.23951	0.9984936	1	1	1	1	0	43	1.0
KMT2C	58508	broad.mit.edu	37	7	151970822	151970822	+	Missense_Mutation	SNP	C	C	A			AC-V29-Tumor-SM-9J46V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V29-Tumor-SM-9J46V	none	g.chr7:151970822C>A	ENST00000355193.2	-	7	1198	c.980G>T	c.(979-981)tGt>tTt	p.C327F	KMT2C_ENST00000262189.6_Missense_Mutation_p.C327F					lysine (K)-specific methyltransferase 2C																		GTGTTCTGGACAAAGCAGGAA	0.383																																														0													247.0	232.0	237.0					7																	151970822.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.980G>T	7.37:g.151970822C>A	ENSP00000347325:p.Cys327Phe			ENST00000355193.2	37		.	.	.	.	.	.	.	.	.	.	C	17.65	3.442088	0.63067	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	D;D	0.90844	-2.74;-2.74	4.78	4.78	0.61160	Zinc finger, PHD-type (1);Protein kinase C-like, phorbol ester/diacylglycerol binding (1);Zinc finger, FYVE/PHD-type (1);	0.000000	0.47852	U	0.000204	D	0.97005	0.9022	H	0.96208	3.785	0.80722	D	1	D	0.76494	0.999	D	0.87578	0.998	D	0.98435	1.0584	10	0.87932	D	0	.	18.1678	0.89734	0.0:1.0:0.0:0.0	.	327	Q8NEZ4	MLL3_HUMAN	F	327	ENSP00000262189:C327F;ENSP00000347325:C327F	ENSP00000262189:C327F	C	-	2	0	MLL3	151601755	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	7.752000	0.85141	2.375000	0.81037	0.585000	0.79938	TGT	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		-7.877498	KEEP		-	10.259717	0.092593	10	98					42.5	3	9	55	67	0.75	0.010729	0.0108261	1	1	0	32.34	0.25	0	0.0	0.0	0.38729	0	41	8277	3	5	7	0	0	0	5.220582e-05	0.003	1	-6.41719	1.0	1	1	1	1	0	108	1.0
CASP8	841	broad.mit.edu	37	2	202149809	202149809	+	Missense_Mutation	SNP	A	A	G			AC-V30-Tumor-SM-9J46W	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V30-Tumor-SM-9J46W	none	g.chr2:202149809A>G	ENST00000358485.4	+	8	1446	c.1250A>G	c.(1249-1251)cAg>cGg	p.Q417R	CASP8_ENST00000432109.2_Missense_Mutation_p.Q358R|CASP8_ENST00000264274.9_Missense_Mutation_p.Q274R|CASP8_ENST00000392259.2_3'UTR|CASP8_ENST00000392266.3_3'UTR|CASP8_ENST00000264275.5_Missense_Mutation_p.Q375R|CASP8_ENST00000323492.7_Missense_Mutation_p.Q343R	NM_001080125.1	NP_001073594.1	Q14790	CASP8_HUMAN	caspase 8, apoptosis-related cysteine peptidase	358.0					activation of caspase activity|activation of pro-apoptotic gene products|cellular component disassembly involved in apoptosis|cellular response to mechanical stimulus|induction of apoptosis by extracellular signals|induction of apoptosis by intracellular signals|positive regulation of I-kappaB kinase/NF-kappaB cascade|proteolysis involved in cellular protein catabolic process|response to tumor necrosis factor	centrosome|cytosol|mitochondrial outer membrane	cysteine-type endopeptidase activity|protein binding			breast(5)|cervix(2)|endometrium(6)|large_intestine(11)|lung(10)|ovary(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(9)|urinary_tract(3)	52.0						TTTTTTATTCAGGCTTGTCAG	0.458										HNSCC(4;0.00038)																									Melanoma(82;831 1348 20716 36952 40159)											0													92.0	95.0	94.0					2																	202149809.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000064012	HGNC:1509	NM_001228	Approved	uc002uxt.1	ENST00000358485.4:c.1250A>G	2.37:g.202149809A>G	ENSP00000351273:p.Gln417Arg		O14676|Q14791|Q14792|Q14793|Q14794|Q14795|Q14796|Q15780|Q15806|Q53TT5|Q8TDI1|Q8TDI2|Q8TDI3|Q8TDI4|Q8TDI5|Q96T22|Q9C0K4|Q9UQ81	ENST00000358485.4	37	CCDS42798.1	.	.	.	.	.	.	.	.	.	.	A	28.7	4.946760	0.92593	.	.	ENSG00000064012	ENST00000392263;ENST00000264274;ENST00000432109;ENST00000264275;ENST00000358485;ENST00000323492;ENST00000444430	T;T;T;T;T;T;T	0.27256	1.68;1.68;1.68;1.68;1.68;1.68;1.68	5.82	5.82	0.92795	Peptidase C14, caspase catalytic (1);Peptidase C14, caspase precursor p45, core (2);Peptidase C14, ICE, catalytic subunit p20 (1);	0.000000	0.85682	D	0.000000	T	0.69672	0.3137	H	0.98918	4.37	0.80722	D	1	D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0	D;D;D;D;D	0.97110	0.977;0.997;1.0;0.999;0.992	T	0.83281	-0.0038	10	0.87932	D	0	.	16.1818	0.81909	1.0:0.0:0.0:0.0	.	274;417;358;343;375	Q14790-3;Q14790-9;Q14790;Q14790-2;Q14790-4	.;.;CASP8_HUMAN;.;.	R	343;274;358;375;417;343;137	ENSP00000376091:Q343R;ENSP00000264274:Q274R;ENSP00000412523:Q358R;ENSP00000264275:Q375R;ENSP00000351273:Q417R;ENSP00000325722:Q343R;ENSP00000394434:Q137R	ENSP00000264274:Q274R	Q	+	2	0	CASP8	201858054	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	9.339000	0.96797	2.225000	0.72522	0.459000	0.35465	CAG	CASP8-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding		protein_coding	OTTHUMT00000256278.3	57.649344	KEEP		+	58.619766	0.96	24	1					74.0	15	13	0	1	0.464286	0.0	0.0	1	0	0	28.33		0	0.0	0.0	0.004656	0	46	8072	125	80	11	0	0	0	0.0001613077	0.003	1	-20.0	0.9999975	1	1	1	1	0	25	0.0
KMT2C	58508	broad.mit.edu	37	7	151917764	151917764	+	Nonsense_Mutation	SNP	G	G	A			AC-V31-Tumor-SM-9J46X	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V31-Tumor-SM-9J46X	none	g.chr7:151917764G>A	ENST00000355193.2	-	23	3774	c.3556C>T	c.(3556-3558)Cag>Tag	p.Q1186*	KMT2C_ENST00000262189.6_Nonsense_Mutation_p.Q1186*					lysine (K)-specific methyltransferase 2C									p.Q1186*(2)									CTCTGTAACTGAGTCATCCCT	0.383																																														2	Substitution - Nonsense(2)	cervix(2)											67.0	63.0	65.0					7																	151917764.0		2203.0	4297.0	6500.0	SO:0001587	stop_gained			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.3556C>T	7.37:g.151917764G>A	ENSP00000347325:p.Gln1186*			ENST00000355193.2	37		.	.	.	.	.	.	.	.	.	.	G	44	10.700319	0.99452	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	.	.	.	4.44	4.44	0.53790	.	0.000000	0.41605	U	0.000844	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.36615	T	0.2	.	17.4147	0.87496	0.0:0.0:1.0:0.0	.	.	.	.	X	1186	.	ENSP00000262189:Q1186X	Q	-	1	0	MLL3	151548697	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	9.351000	0.97073	2.161000	0.67846	0.484000	0.47621	CAG	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		14.651338	KEEP		-	17.645732	0.227273	10	34					49.95	5	10	30	25	0.333333	0.0	0.0	1	0	0	32.44	0.666667	1	0.000219431	0.000245928	0.457914	0	48	7977	227	72	4	6	0	0	0.0001436084	0.003	1	-3.696275	0.9995407	1	1	1	1	0	44	1.0
FBXW7	0	broad.mit.edu	37	4	153245513	153245513	+	Missense_Mutation	SNP	C	C	G			AC-V34-Tumor-SM-9J471	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V34-Tumor-SM-9J471	none	g.chr4:153245513C>G	ENST00000281708.4	-	11	2907	c.1678G>C	c.(1678-1680)Gat>Cat	p.D560H	FBXW7_ENST00000603841.1_Missense_Mutation_p.D560H|FBXW7_ENST00000263981.5_Missense_Mutation_p.D480H|FBXW7_ENST00000393956.3_Missense_Mutation_p.D384H|FBXW7_ENST00000603548.1_Missense_Mutation_p.D560H|FBXW7_ENST00000296555.5_Missense_Mutation_p.D442H	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	560.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				ATTGATGTATCAAGAGATCCA	0.393			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	1	Unknown(1)	haematopoietic_and_lymphoid_tissue(1)											116.0	89.0	98.0					4																	153245513.0		2203.0	4299.0	6502.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1678G>C	4.37:g.153245513C>G	ENSP00000281708:p.Asp560His		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	C	27.4	4.826328	0.90955	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	D;D;D;D	0.89415	-2.51;-2.51;-2.51;-2.51	5.61	5.61	0.85477	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40 repeat, conserved site (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	D	0.97117	0.9058	H	0.98407	4.225	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	D	0.98383	1.0559	10	0.87932	D	0	-20.7958	19.6375	0.95740	0.0:1.0:0.0:0.0	.	384;560;442;480	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	H	560;442;480;384	ENSP00000281708:D560H;ENSP00000296555:D442H;ENSP00000263981:D480H;ENSP00000377528:D384H	ENSP00000263981:D480H	D	-	1	0	FBXW7	153464963	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	7.818000	0.86416	2.640000	0.89533	0.655000	0.94253	GAT	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	12.606834	KEEP		-	13.008798	0.35	7	13					74.36	5	2	11	7	0.285714	0.0	0.0	1	0	0	31.55	0.714286	0	0.0	0.0	0.248553	0	249	7889	173	20	0	0	0	0	4.984666e-05	0.003	1	-17.50747	1.0	1	1	1	1	0	20	0.0
KMT2C	58508	broad.mit.edu	37	7	152007050	152007050	+	Splice_Site	SNP	C	C	T			AC-V34-Tumor-SM-9J471	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V34-Tumor-SM-9J471	none	g.chr7:152007050C>T	ENST00000355193.2	-	6	1068		c.e6+1		KMT2C_ENST00000262189.6_Splice_Site					lysine (K)-specific methyltransferase 2C																		TGTCTACTTACTTCTGTGCTC	0.378																																														0													91.0	80.0	83.0					7																	152007050.0		2203.0	4300.0	6503.0	SO:0001630	splice_region_variant			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.849+1G>A	7.37:g.152007050C>T				ENST00000355193.2	37		.	.	.	.	.	.	.	.	.	.	C	24.0	4.485430	0.84854	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	.	.	.	5.78	5.78	0.91487	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	19.5978	0.95548	0.0:1.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	-	.	.	MLL3	151637983	1.000000	0.71417	1.000000	0.80357	0.970000	0.65996	6.915000	0.75770	2.733000	0.93635	0.655000	0.94253	.	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		26.956586	KEEP	Intron	-	26.956586	0.5	13	13					74.36	7	6	11	3	0.461538	0.0	0.0	1	0	0	31.55	0.538462	1	5.50884e-06	6.72777e-06	0.411799	0	48	8139	131	16	0	0	0	0	4.305601e-05	0.003	1	-20.0	1.0	1	1	1	1	0	26	0.0
FBXW7	0	broad.mit.edu	37	4	153245518	153245518	+	Missense_Mutation	SNP	G	G	A			AC-V34-Tumor-SM-9J471	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V34-Tumor-SM-9J471	none	g.chr4:153245518G>A	ENST00000281708.4	-	11	2902	c.1673C>T	c.(1672-1674)tCt>tTt	p.S558F	FBXW7_ENST00000603841.1_Missense_Mutation_p.S558F|FBXW7_ENST00000263981.5_Missense_Mutation_p.S478F|FBXW7_ENST00000393956.3_Missense_Mutation_p.S382F|FBXW7_ENST00000603548.1_Missense_Mutation_p.S558F|FBXW7_ENST00000296555.5_Missense_Mutation_p.S440F	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	558.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				TGTATCAAGAGATCCACTCAC	0.403			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	1	Unknown(1)	haematopoietic_and_lymphoid_tissue(1)											115.0	87.0	96.0					4																	153245518.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1673C>T	4.37:g.153245518G>A	ENSP00000281708:p.Ser558Phe		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	28.3	4.907349	0.92107	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.74526	-0.85;-0.85;-0.85;-0.85	5.61	5.61	0.85477	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40 repeat, conserved site (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	D	0.90662	0.7071	H	0.94658	3.565	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	D	0.92754	0.6218	10	0.87932	D	0	-11.34	19.6375	0.95740	0.0:0.0:1.0:0.0	.	382;558;440;478	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	F	558;440;478;382	ENSP00000281708:S558F;ENSP00000296555:S440F;ENSP00000263981:S478F;ENSP00000377528:S382F	ENSP00000263981:S478F	S	-	2	0	FBXW7	153464968	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.869000	0.99810	2.640000	0.89533	0.655000	0.94253	TCT	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	20.367348	KEEP		-	20.498113	0.6	9	6					74.36	9	4	4	4	0.692308	0.0	0.0	1	0	0	31.55	0.307692	1	1.61879e-10	2.33316e-10	0.411799	0	321	7908	96	9	0	0	0	0	3.363242e-05	0.003	1	-19.99998	1.0	1	1	1	1	0	15	0.0
